<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">89687</article-id><article-id pub-id-type="doi">10.7554/eLife.89687</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.89687.3</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Short Report</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Synapsin E-domain is essential for α-synuclein function</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-320857"><name><surname>Stavsky</surname><given-names>Alexandra</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8209-3524</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-320858"><name><surname>Parra-Rivas</surname><given-names>Leonardo A</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6707-1255</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund9"/><xref ref-type="other" rid="fund10"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-356904"><name><surname>Tal</surname><given-names>Shani</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-347485"><name><surname>Riba</surname><given-names>Jen</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0009-0004-5016-5636</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-320860"><name><surname>Madhivanan</surname><given-names>Kayalvizhi</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="pa1">‡</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-13188"><name><surname>Roy</surname><given-names>Subhojit</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1571-2735</contrib-id><email>sroy@ucsd.edu</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund7"/><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-91490"><name><surname>Gitler</surname><given-names>Daniel</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9544-3610</contrib-id><email>gitler@bgu.ac.il</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05tkyf982</institution-id><institution>Department of Physiology and Cell Biology, Faculty of Health Sciences and School of Brain Sciences and Cognition, Ben-Gurion University of the Negev</institution></institution-wrap><addr-line><named-content content-type="city">Beer Sheva</named-content></addr-line><country>Israel</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0168r3w48</institution-id><institution>Department of Pathology, University of California, San Diego</institution></institution-wrap><addr-line><named-content content-type="city">La Jolla</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03zj4c476</institution-id><institution>Aligning Science Across Parkinson’s (ASAP) Collaborative Research Network</institution></institution-wrap><addr-line><named-content content-type="city">Chevy Chase</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0168r3w48</institution-id><institution>Department of Neurosciences, University of California, San Diego</institution></institution-wrap><addr-line><named-content content-type="city">La Jolla</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Slutsky</surname><given-names>Inna</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04mhzgx49</institution-id><institution>Tel Aviv University</institution></institution-wrap><country>Israel</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Ron</surname><given-names>David</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/013meh722</institution-id><institution>University of Cambridge</institution></institution-wrap><country>United Kingdom</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn><fn fn-type="present-address" id="pa1"><label>‡</label><p>Arrowhead Pharmaceuticals, Pasadena, United States</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>07</day><month>05</month><year>2024</year></pub-date><volume>12</volume><elocation-id>RP89687</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2023-06-03"><day>03</day><month>06</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2023-06-26"><day>26</day><month>06</month><year>2023</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2023.06.24.546170"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2023-08-08"><day>08</day><month>08</month><year>2023</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.89687.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-02-26"><day>26</day><month>02</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.89687.2"/></event></pub-history><permissions><copyright-statement>© 2023, Stavsky, Parra-Rivas et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Stavsky, Parra-Rivas et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-89687-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-89687-figures-v1.pdf"/><abstract><p>The cytosolic proteins synucleins and synapsins are thought to play cooperative roles in regulating synaptic vesicle (SV) recycling, but mechanistic insight is lacking. Here, we identify the synapsin E-domain as an essential functional binding-partner of α-synuclein (α-syn). Synapsin E-domain allows α-syn functionality, binds to α-syn, and is necessary and sufficient for enabling effects of α-syn at synapses of cultured mouse hippocampal neurons. Together with previous studies implicating the E-domain in clustering SVs, our experiments advocate a cooperative role for these two proteins in maintaining physiologic SV clusters.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>alpha-synuclein</kwd><kwd>synapsin</kwd><kwd>synaptic transmission</kwd><kwd>synaptic terminals</kwd><kwd>presynaptic</kwd><kwd>synaptic vesicles</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001742</institution-id><institution>United States-Israel Binational Science Foundation</institution></institution-wrap></funding-source><award-id>2019248</award-id><principal-award-recipient><name><surname>Roy</surname><given-names>Subhojit</given-names></name><name><surname>Gitler</surname><given-names>Daniel</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003977</institution-id><institution>Israel Science Foundation</institution></institution-wrap></funding-source><award-id>1310/19</award-id><principal-award-recipient><name><surname>Gitler</surname><given-names>Daniel</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003977</institution-id><institution>Israel Science Foundation</institution></institution-wrap></funding-source><award-id>189/22</award-id><principal-award-recipient><name><surname>Gitler</surname><given-names>Daniel</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution>Bergida Endowment on Parkinson's Disease Research</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Gitler</surname><given-names>Daniel</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000065</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution></institution-wrap></funding-source><award-id>R01NS111978</award-id><principal-award-recipient><name><surname>Roy</surname><given-names>Subhojit</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000065</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution></institution-wrap></funding-source><award-id>P30NS047101</award-id><principal-award-recipient><name><surname>Roy</surname><given-names>Subhojit</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100019736</institution-id><institution>Farmer Family Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Roy</surname><given-names>Subhojit</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100018231</institution-id><institution>Aligning Science Across Parkinson’s</institution></institution-wrap></funding-source><award-id>ASAP-020495</award-id><principal-award-recipient><name><surname>Roy</surname><given-names>Subhojit</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100006309</institution-id><institution>American Parkinson Disease Association</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Parra-Rivas</surname><given-names>Leonardo A</given-names></name></principal-award-recipient></award-group><award-group id="fund10"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100013301</institution-id><institution>Parkinson's Foundation</institution></institution-wrap></funding-source><award-id>PF-LAUNCH-1046253</award-id><principal-award-recipient><name><surname>Parra-Rivas</surname><given-names>Leonardo A</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Alpha-synuclein binding to the synapsin E-domain is essential and sufficient for their cooperation in attenuating synaptic-vesicle trafficking and neurotransmission.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Substantial evidence links the small presynaptic protein α-syn to neurodegenerative diseases, collectively called synucleinopathies. The normal function of α-syn has been investigated for over a decade, and a prevailing view is that α-syn is a physiologic attenuator of neurotransmitter release. Modest overexpression of α-syn dampens synaptic responses (<xref ref-type="bibr" rid="bib21">Nemani et al., 2010</xref>; <xref ref-type="bibr" rid="bib26">Scott et al., 2010</xref>; <xref ref-type="bibr" rid="bib37">Wang et al., 2014</xref>; <xref ref-type="bibr" rid="bib33">Sun et al., 2019</xref>; <xref ref-type="bibr" rid="bib3">Atias et al., 2019</xref>), and analogously, eliminating α-syn leads to phenotypes consistent with augmented synaptic release (<xref ref-type="bibr" rid="bib1">Abeliovich et al., 2000</xref>; <xref ref-type="bibr" rid="bib38">Yavich et al., 2004</xref>; <xref ref-type="bibr" rid="bib39">Yavich et al., 2006</xref>; <xref ref-type="bibr" rid="bib28">Senior et al., 2008</xref>; <xref ref-type="bibr" rid="bib13">Greten-Harrison et al., 2010</xref>; <xref ref-type="bibr" rid="bib2">Anwar et al., 2011</xref>), although the latter has not been seen in all studies (<xref ref-type="bibr" rid="bib5">Burré et al., 2010</xref>). At a cellular level, synaptic attenuation is likely mediated by effects of α-syn on vesicle organization and trafficking, which are even seen in minimal in vitro systems, where recombinant α-syn clusters small synaptic-like vesicles (<xref ref-type="bibr" rid="bib9">Diao et al., 2013</xref>; <xref ref-type="bibr" rid="bib33">Sun et al., 2019</xref>). An emerging model is that α-syn plays a role in the organization and mobilization of SVs, that in turn regulates SV-recycling and neurotransmitter release; however, underlying mechanisms are unknown.</p><p>Work over several decades has shown that temporal and spatial regulation of the SV cycle is achieved by the cooperative effort of diverse groups of proteins, such as Muncs/SNAREs – orchestrating SV docking, priming, fusion – and sequential assembly of a variety of endocytosis-related proteins that build a platform for efficient membrane retrieval. Reasoning that an understanding of functional α-syn partners would offer meaningful insight into α-syn function, we have been combining SV-recycling assays with structure-function approaches to identify the protein-network in which α-syn operates at the synapse. Using this approach, we recently found that the physiologic effects of α-syn at the synapse requires synapsins (<xref ref-type="bibr" rid="bib3">Atias et al., 2019</xref>). While modest over-expression of α-syn in wild-type (WT) cultured hippocampal neurons attenuated SV recycling, there was no effect in neurons lacking all synapsins, indicating that synapsins were necessary to enable α-syn functionality. Reintroduction of the canonical synapsin isoform (synapsin Ia) reinstated α-syn mediated attenuation, confirming functional cooperation between α-syn and synapsins (<xref ref-type="bibr" rid="bib3">Atias et al., 2019</xref>).</p></sec><sec id="s2" sec-type="results"><title>Results</title><p>Synapsins are a family of cytosolic proteins with known roles in maintaining physiologic SV clusters (<xref ref-type="bibr" rid="bib7">Cesca et al., 2010</xref>; <xref ref-type="bibr" rid="bib22">Orenbuch et al., 2012</xref>; <xref ref-type="bibr" rid="bib40">Zhang and Augustine, 2021</xref>), and recent work supports a model where SVs are confined within synapsin-based protein condensates (<xref ref-type="bibr" rid="bib20">Milovanovic et al., 2018</xref>). Alternative splicing of three synapsin genes gives five major isoforms. Both synapsins and synucleins are peripherally associated with SVs via the N-terminus, while C-terminal regions are more variable and structurally disordered (<xref ref-type="bibr" rid="bib31">Song and Augustine, 2023</xref>). Depending on the isoform, the C-terminus of synapsin has two to three structurally distinct domains, and substantial evidence indicates that this domain-variability leads to isoform-specific functions (<xref ref-type="bibr" rid="bib30">Song and Augustine, 2015</xref>; <xref ref-type="bibr" rid="bib31">Song and Augustine, 2023</xref>). Reasoning that identifying the specific synapsin domain/isoform that bound to α-syn and facilitated α-syn function would offer mechanistic insight into α-syn biology, we systematically evaluated effects of each synapsin isoform in enabling the physiologic effects of α-syn. For these experiments, we used pHluorin assays that report exo/endocytic SV recycling. pHluorin is a pH-sensitive GFP that acts as a sensor for pH changes, and in our experiments, the probe is tagged to the transmembrane presynaptic protein synaptophysin, and targeted to the interior of SVs [called ‘sypHy’, see <xref ref-type="bibr" rid="bib25">Royle et al., 2008</xref>]. In resting SVs, sypHy is quenched, as the pH is acidic (~5.5). However, upon stimulation, SVs fuse with the presynaptic plasma membrane, resulting in pH-neutralization and a concomitant rise in fluorescence, which is subsequently quenched as the vesicles are endocytosed and reacidified (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Fluorescence fluctuations in this assay are a measure of SV exo/endocytosis, and at the end of the experiment, all vesicles can be visualized by adding NH<sub>4</sub>Cl to the bath (alkalinization). As reported previously, overexpression of h-α-syn attenuated SV recycling in WT hippocampal cultured neurons, but there was no effect in neurons from mice lacking all synapsins – synapsin triple knockout or TKO mice (<xref ref-type="fig" rid="fig1">Figure 1B–C</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Screening for synapsin isoforms that allow α-syn functionality.</title><p>(<bold>A</bold>) Schematic showing pH-sensitive sensor sypHy and principle of pHluorin experiments to quantitatively evaluate the SV cycle (see main text and methods for more details). (<bold>B</bold>) Elimination of all synapsins block α-syn functionality at synapses. <underline>Left</underline>: Schematic showing design of pHluorin experiments. WT or synapsin TKO cultured hippocampal neurons were co-transduced at 5 days in vitro (DIV) with h-α-syn:mCherry (or mCherry as control) and sypHy, and imaged at 14–15 DIV. <underline>Right</underline>: Stimulation-induced sypHy fluorescence traces (300 action potentials at 20 Hz, delivered at t=0 s – for clarity, symbols only mark every other mean ± SEM ΔF/F<sub>0</sub> value in all sypHy traces). Note that while h-α-syn over-expression (orange) attenuated sypHy fluorescence in WT neurons, there was no effect in neurons from mice lacking all synapsins (TKO). All sypHy data quantified in (<bold>C</bold>). (<bold>C</bold>) Quantification of peak ΔF/F<sub>0</sub> sypHy values (bars: mean ± SEM). A total of 12–19 coverslips were analyzed for each condition, from at least three separate cultures (***p=9e-7, ns p=0.45, student’s t-test). (<bold>D</bold>) Domain structure of the five main synapsin isoforms. (<bold>E</bold>) Experimental design to identify the synapsin isoform that reinstated α-syn functionality, Synapsin TKO neurons were co-transduced at 5 DIV with each synapsin isoform, h-α-syn, and sypHy; and imaged at 14–15 DIV. (<bold>F</bold>) SypHy fluorescence traces (mean ± SEM). Note that h-α-syn(orange) attenuates SV recycling only if the neurons are also co-expressing the ‘a’ isoforms – synapsins Ia, IIa, and IIIa (300 action potentials at 20 Hz, delivered at t=0 sec). Data quantified in G. (<bold>G</bold>) Quantification of peak ΔF/F<sub>0</sub> sypHy values (bars: mean ± SEM). 13–26 coverslips from at least three separate cultures were analyzed for each condition (from left to right: ***p=0.0009, ns p=0.62, ***p=0.00005, ns p=0.99, **p=0.004, student’s t test).</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Tabular data and statistical analyses for graphs presented in panels B, C, F, G.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89687-fig1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89687-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Effects of h-α-syn over-expression are largely due to suppression of exocytosis.</title><p>(<bold>A</bold>) Data from sypHy experiments where reacidification was blocked by bafilomycin (Baf), allowing isolated evaluation of exocytosis only (also see results). Note that h-α-syn over-expression attenuated synaptic exocytosis in WT neurons (left), while there was no effect in synapsin TKO neurons (middle). Reintroduction of tagBFP:synapsin Ia reinstated the h-α-syn-mediated synaptic attenuation (right). All pHluorin data quantified in (<bold>B</bold>). 9–22 coverslips from at least three independent cultures (***p=1.9e-5 Mann-Whitney test, p=0.22 Student’s t-test, **p=0.008 Student’s t-test). (<bold>C</bold>) A representative trace showing how the fluorescence decay was quantified to evaluate endocytosis in the sypHy experiments (also see Results). (<bold>D–E</bold>) Fluorescence decay analyses of h-α-syn over-expression in WT and synapsin TKO neurons (<bold>D</bold>), as well as in synapsin TKO neurons where each synapsin isoform was reintroduced (<bold>E</bold>). Note that there were no significant differences in any of these groups. All data in this figure are represented as mean +/- SEM. Ten to 26 coverslips from at least three independent cultures (D: p=0.36; E: p=0.85 both Kruskal Wallis ANOVA).</p><p><supplementary-material id="fig1s1sdata1"><label>Figure 1—figure supplement 1—source data 1.</label><caption><title>Tabular data and statistical analyses for graphs presented in panels A, B, D, and E.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89687-fig1-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89687-fig1-figsupp1-v1.tif"/></fig></fig-group><p>The synapsin family has five main isoforms, Ia Ib, IIa, IIb, and IIIa (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). To determine synapsin isoforms that enable α-syn functionality, we overexpressed h-α-syn in cultured neurons from synapsin TKO mice and systematically reintroduced each synapsin isoform, with the goal of identifying synapsin isoforms that reinstated α-syn-induced synaptic attenuation (see plan in <xref ref-type="fig" rid="fig1">Figure 1E</xref>). Reintroduction of Synapsin Ia (containing domains A-E) in this setting reinstated α-syn functionality (<xref ref-type="fig" rid="fig1">Figure 1F</xref>, left-panel; these changes are due to altered exocytosis, see <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A–B</xref>). However, interestingly, only synapsins Ia, IIa, and IIIa enabled h-α-syn-mediated synaptic attenuation, whereas synapsins Ib and IIb had no effect (<xref ref-type="fig" rid="fig1">Figure 1F</xref>, quantified in <xref ref-type="fig" rid="fig1">Figure 1G</xref>). These effects were likely due to exocytosis as noted above, as quantification of the fluorescence decay-kinetics – which is a measure of endocytosis – did not reveal any changes (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C–E</xref>). One prediction of the pHluorin experiments is that the synapsin isoforms that allow for α-syn functionality would also be the ones that bind to α-syn. To test this, we performed co-immunoprecipitation experiments in neuronal cell lines, where we co-transfected neuro-2a cells with myc-tagged h-α-syn and each synapsin isoform (fluorescent-tagged), immunoprecipitated the synapsin isoform, and determined amounts of co-immunoprecipitated α-syn by western blotting (schematic in <xref ref-type="fig" rid="fig2">Figure 2A</xref>). While synapsins Ia, IIa, and IIIa bound robustly to h-α-syn, binding of synapsins Ib and IIb was much lower (<xref ref-type="fig" rid="fig2">Figure 2B</xref>, quantified in <xref ref-type="fig" rid="fig2">Figure 2C</xref>). Taken together, these experiments indicate that only three synapsin isoforms (Ia, IIa, and IIIa) can robustly bind to α-syn and reinstate functional effects of α-syn in this setting. Since the E-domain, within the variable C-terminus, is common to these three synapsin isoforms – and absent in the others (see domain-structure in <xref ref-type="fig" rid="fig2">Figure 2D</xref>) – we reasoned that the E-domain was the bona fide α-syn binding-site, and also responsible for facilitating α-syn functionality.</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Interaction of synapsin isoforms with h-α-syn.</title><p>(<bold>A</bold>) Workflow for co-immunoprecipitation experiments in neuro2a cells. (<bold>B</bold>) Western blots from co-immunoprecipitation experiments show that the synapsin isoforms Ia, IIa, and IIIa associate more robustly with h-α-syn (top panel), when compared to synapsins Ib and IIb (a non-specific band is marked with an asterisk). (<bold>C</bold>) Quantification of blots in (<bold>B</bold>) n=5, all data presented as mean ± SEM (a vs. b isoform, **p=0.003, ***p=0.0003, Student’s t-test). (<bold>D</bold>) Schematic showing synapsin isoforms and their variable domains. Note that the E-domain is common between synapsins Ia, IIa, and Iia. (<bold>E</bold>) Workflow for pulldown of GST-tagged h-α-syn WT/deletions/scrambled mutations after incubation with mouse brain lysates. Equivalent amounts of immobilized GST α-syn variants were used. (<bold>F</bold>) Schematic showing α-syn regions that were scrambled (amino acids between 96–140 and 96–110). (<bold>G</bold>) <underline>Top</underline>: Samples from GST-pulldown were analyzed by NuPAGE and immunoblotted with an antibody against synapsin I (top panel). <underline>Bottom</underline>: Ponceau staining shows equivalent loading of fusion proteins. Note that full-length h-α-syn bound synapsin I from mouse brains (lane 2), while deletion of the h-α-syn C-terminus (amino acids 96–140, lane 3) eliminated this interaction. Lanes 4–7 show that the sequence within amino acids 96–110 of h-α-syn is critical for binding to synapsin I. All western blots are quantified below (n=3). Data presented as mean ± SEM (**p=0.003, **p=0.002, ns p=0.99, ns p=0.98, **p=0.004, **p=0.004, comparing to full-length h-α-syn, one-way ANOVA with Tukey’s posthoc test).</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Tabular data and statistical analyses for graphs shown in panels C and G.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89687-fig2-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig2sdata2"><label>Figure 2—source data 2.</label><caption><title>Full western blots for segments shown in panel B.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-89687-fig2-data2-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig2sdata3"><label>Figure 2—source data 3.</label><caption><title>Full western blots for segments shown in panel G.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-89687-fig2-data3-v1.pdf"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89687-fig2-v1.tif"/></fig><p>In parallel experiments, we also narrowed down the reciprocal region in α-syn bound to synapsin. Toward this, we designed GST-pulldown assays to test the interaction of various h-α-syn sequences with mouse brain synapsins. In these experiments, beads with GST-tagged h-α-syn (WT, deletions, and scrambled variants) were incubated with mouse brain lysates, and brain synapsins binding to α-syn were evaluated by western blotting (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). <xref ref-type="fig" rid="fig2">Figure 2F</xref> shows how the scrambled variants were designed. While synapsins bound to GST-tagged WT-h-α-syn, deletion of the C-terminus (α-syn 96–140) eliminated this interaction (<xref ref-type="fig" rid="fig2">Figure 2G</xref>, lanes 1–3). Regions within amino acids 96–110 of α-syn were critical in binding synapsin, as this minimal region bound to synapsin (<xref ref-type="fig" rid="fig2">Figure 2G</xref>, lanes 4–5), and scrambling the amino acids within this region – while keeping the other sequences intact – eliminated this interaction (<xref ref-type="fig" rid="fig2">Figure 2G</xref>, lanes 6–7). Data from all western blots is quantified in <xref ref-type="fig" rid="fig2">Figure 2G</xref> – bottom. Together, these experiments identify amino-acids 96–110 of α-syn as the region binding to synapsin.</p><p>To test if the E-domain was <italic>necessary</italic> for enabling α-syn functionality, we generated a synapsin-Ia construct where the amino acid sequences of the E-domain were scrambled (<xref ref-type="fig" rid="fig3">Figure 3A</xref>, synapsin-Ia<sup>ScrE</sup>). As shown previously, expression of WT synapsin-Ia enables α-syn-mediated synaptic attenuation in neurons lacking all synapsins (<xref ref-type="fig" rid="fig1">Figure 1F</xref>, leftmost panel). We reasoned that if the E-domain enabled α-syn functions and mediated synapsin/α-syn interactions in these experiments, scrambling this region should abolish such synapsin-dependent functions. Towards this, we used pHluorin assays in synapsin TKO neurons, asking if synapsin-Ia<sup>ScrE</sup> would fail to reinstate α-syn functionality (schematic in <xref ref-type="fig" rid="fig3">Figure 3B</xref>). Indeed, while overexpressed h-α-syn was able to attenuate synaptic responses in the presence of WT-Synapsin-Ia in synapsin TKO neurons, Synapsin-Ia<sup>ScrE</sup> failed to have any effect (<xref ref-type="fig" rid="fig3">Figure 3C</xref>), despite the detection of similar quantities of both at synapses (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). Analogously, in neuro2a co-immunoprecipitation experiments to test binding of WT-Synapsin-Ia or Synapsin-Ia<sup>ScrE</sup> to α-syn, WT h-α-syn bound to Synapsin-Ia, but not to Synapsin-Ia<sup>ScrE</sup> (<xref ref-type="fig" rid="fig3">Figure 3D</xref>), indicating that the E-domain is critical in mediating this interaction.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>The synapsin E-domain is necessary and sufficient for enabling α-syn functionality.</title><p>(<bold>A</bold>) Schematic showing synapsin Ia scrambled E-domain sequence (synapsin Ia<sup>scr-E</sup>). Numbers depict amino acid positions, letters in the inset depict amino-acids. Note that the WT amino acids are randomized in the scrambled mutant. (<bold>B</bold>) Design of sypHy experiments co-expressing synapsin Ia<sup>scr-E</sup> and h-α-syn in cultured neurons from synapsin TKO mice. (<bold>C</bold>) Stimulation-induced sypHy fluorescence traces (300 action potentials at 20 Hz, delivered at t=0 sec). Note that while h-α-syn attenuated sypHy fluorescence in synapsin TKO neurons expressing synapsin Ia, h-α-syn had no effect in neurons expressing synapsin Ia<sup>scr-E</sup>. Insets: Quantification of peak ΔF/F<sub>0</sub> sypHy values (bars: mean ± SEM). Ten to 16 coverslips from at least three separate cultures were analyzed for each condition (***p=0.0007, ns p=0.67, one-way ANOVA with Tukey’s posthoc analysis). (<bold>D</bold>) <underline>Top</underline>: Schematic for co-immunoprecipitation experiments, to test the interaction of h-α-syn with WT synapsin Ia or synapsin Ia<sup>scr-E</sup>. Neuro2a cells were co-transfected with myc-tagged α-syn and respective YFP-tagged synapsin Ia, and the YFP was immunoprecipitated. <underline>Bottom</underline>: Note that h-α-syn co-immunoprecipitated with synapsin Ia, but not synapsin Ia<sup>scr-E</sup>; quantification of the gels below (n=4, all data are means ± SEM ***p&lt;0.001, Student’s t test – a non-specific band is marked with an asterisk). (<bold>E</bold>) Schematic of experiments to test if the synapsin E-domain is sufficient to enable α-syn functionality in synapsin TKO neurons. Synapsin-E (a 46 amino acid sequence) was fused to the C-terminus of sypHy, so that upon expression in neurons, the E-domain would be present on the cytosolic surface of Svs. (<bold>F</bold>) SypHy fluorescence traces (mean ± SEM). Note that while h-α-syn (orange) was unable to attenuate SV recycling in synapsin TKO neurons (as expected), diminished synaptic responses were seen when the E-domain was present. Insets: Quantification of peak ΔF/F<sub>0</sub> sypHy values (bars: mean ± SEM). Twelve 19 coverslips from at least three separate cultures were analyzed for each condition (ns p=0.89, ***p=2.8e-7, one-way ANOVA with Tukey’s posthoc analysis).</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Tabular data and statistical analyses for graphs shown in panels C, D and F.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89687-fig3-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig3sdata2"><label>Figure 3—source data 2.</label><caption><title>Full western blots for segments shown in panel D.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-89687-fig3-data2-v1.pdf"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89687-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Similar synaptic of localization of synapsin Ia and synapsin Ia<sup>Scr-E</sup> in synapsin TKO neurons.</title><p>(<bold>A</bold>) Schematic of experiments to evaluate quantitative localization of tagBFP:synapsin Ia and tagBFP:synapsin Ia<sup>Scr-E</sup> in synapsin TKO neurons (with and without h-α-syn over-expression). Neurons were immunostained for synapsin I (for reliable visualization of the transduced synapsin constructs), as well as for the SV-marker vGlut1 (to confidently identify synapses). (<bold>B</bold>) Representative images showing equivalent immunofluorescence of synapsin Ia and synapsin Ia<sup>Scr-E</sup> at synapses. Over-expression of h-α-syn did not affect their synaptic fluorescence. (<bold>C</bold>) Quantified synaptic fluorescence data, represented as mean +/- SEM, 15–16 coverslips from at least three independent cultures were analyzed for each condition. ns p=0.52, ns p=0.14, one-way ANOVA.</p><p><supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>Tabular data and statistical analyses for graph shown in panel C.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89687-fig3-figsupp1-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig3s1sdata2"><label>Figure 3—figure supplement 1—source data 2.</label><caption><title>Raw images.</title><p>Full images of anti-synapsin I and anti-vGlut1 immunofluorescence channels containing the details shown in panel B (marked with white dashed square).</p></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89687-fig3-figsupp1-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89687-fig3-figsupp1-v1.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>Synaptic targeting of synapsin E-domain constructs in synapsin null neurons.</title><p>(<bold>A</bold>) Schematic of experiments to evaluate synaptic targeting of synapsin E-domain constructs in synapsin TKO neurons. Note that EGFP is tagged to the E-domain in these experiments. (<bold>B</bold>) The EGFP:E-domain construct was diffusely distributed in neurons and not enriched to synapses (marked by immunostaining of VGlut1). A representative image showing that the E-domain construct is not targeted to synapses (green: EGFP:E-domain, magenta: vGlut1). (<bold>C</bold>) Over-expression of synapsin E-domain in the context of excessive α-syn did not have any effect on SV recycling (as determined by sypHy experiments), presumably because the E-domain fails to enrich at synapses. Data shown as mean mean ± SEM, 11–20 coverslips from at least 3 independent cultures were analyzed for each condition (p=0.16, Kruskal-Wallis ANOVA). (<bold>D</bold>) Representative images illustrating synaptic localization of the E-domain tagged to sypHy (green: sypHy:E-domain, magenta: vGlut1). (<bold>E</bold>) Expression of sypHy:E-domain in synapsin TKO neurons enhances the synaptic enrichment of h-α-syn. Synaptic enrichment (see Methods section) of h-α-syn was measured in synapsin TKO neurons expressing either sypHy or sypHy-E-domain. We observed significantly higher enrichment of h-α-syn in the latter. Data shown as mean ± SEM, 23 to 25 coverslips from three independent cultures were analyzed for each condition (**p=0.009, Mann-Whitney U-test).</p><p><supplementary-material id="fig3s2sdata1"><label>Figure 3—figure supplement 2—source data 1.</label><caption><title>Tabular data and statistical analyses for graphs shown in panels C and E.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89687-fig3-figsupp2-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig3s2sdata2"><label>Figure 3—figure supplement 2—source data 2.</label><caption><title>Raw images.</title><p>Full images of EGFP:E-domain and anti-vGlut1 immunofluorescence channels containing the details shown in panel B, and the full images of sypHy:E-domain and anti-vGlut1 immunofluorescence channels containing the details shown in panel D (marked with white dashed square).</p></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89687-fig3-figsupp2-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89687-fig3-figsupp2-v1.tif"/></fig></fig-group><p>Next, we tested if the synapsin-E domain was <italic>sufficient</italic> for enabling α-syn functionality. Toward this, we first over-expressed the E-domain in synapsin TKO neurons, along with h-α-syn and sypHy (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2A</xref>), with the overall intention of evaluating SV-recycling in this setting. However, we found that the E-domain by itself was not targeted to synapses (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2B</xref>) – consistent with the known biology of synapsins (<xref ref-type="bibr" rid="bib12">Gitler et al., 2004</xref>) – and expectedly, the E-domain had no effect on SV-recycling in pHluorin assays (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2C</xref>). To allow the E-domain to operate in a context where it would be ‘functionally available’, we fused the synapsin E-domain to the C-terminus of sypHy. Since in this scenario, the small synapsin fragment would be localized to the cytosolic surface of SVs and target to synapses (<xref ref-type="fig" rid="fig3">Figure 3E</xref> and <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2D</xref>), we reasoned that such placing of the E-domain in the right cellular context may be sufficient to enable α-syn functionality. Indeed, forced targeting of the synapsin E-domain to the surface of SVs enhanced α-syn enrichment in synapses (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2E</xref>), and restored α-syn mediated synaptic attenuation in synapsin null neurons (<xref ref-type="fig" rid="fig3">Figure 3F</xref>), suggesting that the E-domain was sufficient to reinstate the functional interplay between α-syn and synapsins. Collectively, the evidence makes a strong case that the synapsin E-domain is both necessary and sufficient to allow α-syn functionality at synapses.</p><p>Previous studies have shown that loss of all synapsins disrupt the tight clustering of SVs that is normally seen in cultured hippocampal neurons, leading to a reduced number of SVs within the bouton-boundary and an increase in vesicles spilling out into the adjacent axon [(<xref ref-type="bibr" rid="bib22">Orenbuch et al., 2012</xref>), and see <xref ref-type="fig" rid="fig4">Figure 4A</xref>]. One possibility in our α-syn over-expression experiments is that excessive α-syn can bind to endogenous synapsin molecules (presumably via the E-domain) and prevent the normal functionality of synapsins (i.e. ability to cluster SVs). Dispersion of SVs can be quantified using ‘full-width half-max’ (FWHM) analysis, which is a quantitative measure of the extent of protein-dispersion at synapses (<xref ref-type="bibr" rid="bib22">Orenbuch et al., 2012</xref>; <xref ref-type="bibr" rid="bib37">Wang et al., 2014</xref>). Briefly, combined attenuation and dispersion of synaptic proteins would cause an increase in FWHM (see <xref ref-type="fig" rid="fig4">Figure 4B</xref>). As shown in <xref ref-type="fig" rid="fig4">Figure 4C</xref>, loss of synapsins lead to an overall reduction in the intensity of SV-staining at boutons (<xref ref-type="fig" rid="fig4">Figure 4C</xref>, left), as well as increased FWHM (<xref ref-type="fig" rid="fig4">Figure 4C</xref>, right). To examine SV dispersion in a α-syn over-expression setting, we cultured neurons from WT or synapsin TKO mice, and transduced either h-α-syn alone (in neurons from WT mice), or h-α-syn, along with various synapsin isoforms (in neurons from synapsin TKO mice – see strategy in <xref ref-type="fig" rid="fig4">Figure 4D</xref>). As shown in <xref ref-type="fig" rid="fig4">Figure 4E</xref>, over-expression of h-α-syn led to an attenuation/dispersion of SV-intensities (increased FWHM) in WT neurons, but had no effect in synapsin TKO neurons. Over-expression of Ia/IIa synapsin isoforms (but not Ib/IIb isoforms) also led to SV dispersion (IIIa was not tested). At first glance these data seem to contradict studies from many groups showing that α-syn clusters SVs (<xref ref-type="bibr" rid="bib9">Diao et al., 2013</xref>; <xref ref-type="bibr" rid="bib37">Wang et al., 2014</xref>; <xref ref-type="bibr" rid="bib33">Sun et al., 2019</xref>), but we surmise that the AAV-mediated over-expression of α-syn in this setting creates a scenario where excessive α-syn binds to and displaces native synapsin molecules from SVs, or may disrupt synapsin-based protein condensates (<xref ref-type="bibr" rid="bib15">Hoffmann et al., 2021</xref>; <xref ref-type="bibr" rid="bib31">Song and Augustine, 2023</xref>; <xref ref-type="bibr" rid="bib16">Hoffmann et al., 2023</xref>).</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Synapsin-dependent redistribution of synaptic vesicles by α-syn overexpression<bold>.</bold></title><p>(<bold>A</bold>) Representative images from WT or synapsin TKO neurons immunostained with an SV marker (vGlut1); zoomed insets marked by yellow boundaries. Note that the compact clustering of SVs is lost in synapsin-null neurons. (<bold>B</bold>) FWHM as a quantitative means to determine spreading of fluorophores at synapses (also see Results). Note that an increase in FWHM corresponds to a decrease in intensity and increased spreading of fluorescence within a bouton. (<bold>C</bold>) Quantification of synaptic fluorescence in WT and synapsin TKO neurons. Overall intensities are decreased in TKO synapses (left), and FWHM is increased (right), compared to WT synapses; consistent with a spreading of SVs in the synapsin null setting. (<bold>D</bold>) Experimental plan to determine effects of h-α-syn over-expression on the overall distribution of SVs in WT and synapsin TKO neurons. (<bold>E</bold>) FWHM of vGlut1 staining at synapses is augmented by h-α-syn over-expression in WT neurons, but not in neurons from synapsin TKO mice. Reintroduction of synapsins Ia/IIa (but not Ib/IIb) in the setting of h-α-syn over-expression rescues the changes in vGlut1-FWHM (<bold>F</bold>). All data in this figure are represented as mean +/-SEM. Nine to 28 coverslips from at least three independent cultures were analyzed for C, E, and F (C, left: ***p=0.0006, Mann-Whitney U-test; right: see E; E: ***p=4e-8, ns p=0.92, one-way ANOVA with Tukey’s posthoc analysis; F, left: ***p=2.7e-4, ns p=1.0, Kruskal-Wallis ANOVA with Dunn’s posthoc test; F, right: **p=0.001, ns p=0.52, one-way ANOVA with Tukey’s posthoc analysis).</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Raw images.</title><p>Full images of anti-vGlut1 immunofluorescence channels in WT and synapsin TKO neurons, containing the details shown in panel A (marked with white dashed square).</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89687-fig4-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4sdata2"><label>Figure 4—source data 2.</label><caption><title>Tabular data and statistical analyses for graphs shown in panels C, E, and F.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89687-fig4-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89687-fig4-v1.tif"/></fig></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Precise organization of vesicles at synapses is critical for synaptic function (<xref ref-type="bibr" rid="bib8">Denker and Rizzoli, 2010</xref>). Typically, each synapse has clusters of dozens to hundreds of SVs, and these vesicles are classified into different pools based on their ability to participate in exocytosis, and their physical proximity to the site of exocytosis (active zone). SVs within the readily releasable pool are docked at the active zone and can rapidly fuse with the plasma membrane in response to an action potential. On the other hand, SVs within the much larger reserve pool are distal to the active zone and are thought to help replenish SVs following exocytosis. Actively recycling vesicles comprise the recycling pool. Studies over several decades have shown that functional perturbation of synapsins selectively reduces the number of SVs in the reserve pool, establishing a role for synapsin in maintaining SV clusters within this pool [reviewed in <xref ref-type="bibr" rid="bib40">Zhang and Augustine, 2021</xref>]. Previous studies have also explored the role of the E-domain in various model systems. Microinjecting domain-E antibodies into lamprey giant axons dispersed the distal cluster of SVs (<xref ref-type="bibr" rid="bib24">Pieribone et al., 1995</xref>), suggesting that this domain has a role in organizing the reserve pool. Injection of a peptide from the E-domain into squid giant synapses also dispersed the distal SV cluster, while docked SVs remained intact (<xref ref-type="bibr" rid="bib14">Hilfiker et al., 1998</xref>), indicating that interfering with this domain in different ways resulted in the same phenotype – disruption of the reserve pool of SVs.</p><p>Thus, the current view is that the synapsin E-domain has an important role in maintaining the distal reserve pool SV clusters, although this domain has other independent roles in SV exocytosis that are not well defined (<xref ref-type="bibr" rid="bib30">Song and Augustine, 2015</xref>). In this context, α-syn has also been long thought to play roles in SV organization and trafficking. First, the N-terminus of α-syn adopts a helical structure in the presence of small synaptic-like vesicles (<xref ref-type="bibr" rid="bib6">Burré et al., 2018</xref>), and can also directly modulate vesicle shape (<xref ref-type="bibr" rid="bib36">Varkey et al., 2010</xref>). In cell-free systems, recombinant α-syn can cluster synaptic-like vesicles (<xref ref-type="bibr" rid="bib9">Diao et al., 2013</xref>; <xref ref-type="bibr" rid="bib33">Sun et al., 2019</xref>), and experiments with cultured neurons also support the idea that α-syn can cluster SVs (<xref ref-type="bibr" rid="bib37">Wang et al., 2014</xref>). For example, induced multimerization of α-syn at synapses clusters synaptic vesicles (<xref ref-type="bibr" rid="bib37">Wang et al., 2014</xref>), and α-syn overexpression also diminished vesicle trafficking between synaptic boutons (<xref ref-type="bibr" rid="bib27">Scott and Roy, 2012</xref>), which may reflect clustering of SVs by α-syn. Adjacent vesicles may also be directly tethered by α-syn (<xref ref-type="bibr" rid="bib11">Fusco et al., 2016</xref>; <xref ref-type="bibr" rid="bib18">Lautenschläger et al., 2018</xref>), thus α-syn-dependent organization and corralling of SVs are important clues to its function. Interestingly, a recent study showed that injection of an antibody to the N-terminus of α-syn into lamprey giant axons also led to a loss of SVs (<xref ref-type="bibr" rid="bib10">Fouke et al., 2021</xref>) – resembling the SV disruption caused by synapsin E-domain injections (<xref ref-type="bibr" rid="bib24">Pieribone et al., 1995</xref>; <xref ref-type="bibr" rid="bib14">Hilfiker et al., 1998</xref>) – although both reserve and readily-releasable pools were depleted with α-syn injections. Our results support co-regulation of SV organization by both α-syn and synapsin, involving the synapsin E-domain. Additionally, α-syn has also been implicated in promoting SNARE complex formation (<xref ref-type="bibr" rid="bib5">Burré et al., 2010</xref>), facilitating endocytosis (<xref ref-type="bibr" rid="bib35">Vargas et al., 2014</xref>), and may participate in fusion-pore opening (<xref ref-type="bibr" rid="bib19">Logan et al., 2017</xref>). Further work is needed to clarify whether these different effects of α-syn are linked, or whether they reflect functionality in distinct neuronal states (for instance in resting versus active neurons). In summary, our studies open the door to further mechanistic investigations into the functional interacting partners of α-syn, which will be important to uncover the myriad functions of this enigmatic protein. More broadly, our structure-function experiments place α-syn in a functional context with its interacting partners at the synapse, offering new insight into α-syn biology.</p></sec><sec id="s4" sec-type="methods"><title>Methods</title><sec id="s4-1"><title>Animals, cell lines, antibodies, and DNA constructs</title><p>Animal studies were performed following the guidelines of the Ben-Gurion University Institutional Committee for Ethical Care and Use of Animals in Research (protocol IL-52-07-2019A) or of IACUC (UCSD protocol S19073). Synapsin triple knock-out (TKO) mice (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:MMRRC_041434-JAX">MMRRC_041434-JAX</ext-link>) were backcrossed onto the C57BL/6 background as described previously (<xref ref-type="bibr" rid="bib12">Gitler et al., 2004</xref>; <xref ref-type="bibr" rid="bib4">Boido et al., 2010</xref>; <xref ref-type="bibr" rid="bib29">Shulman et al., 2015</xref>), and C57BL/6JRccHsd mice (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_ENV:HSD-043">IMSR_ENV:HSD-043</ext-link>) served as WT controls. The following cell lines were obtained from ATCC and maintained using standard protocols: HEK293-T (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:CVCL_0063">CVCL_0063</ext-link>) and Neuro2A (TKG Cat#TKG 0509, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:CVCL_0470">CVCL_0470</ext-link>). Mycoplasma contamination was tested regularly. The following antibodies were used for immunofluorescence experiments: goat anti-vGlut1 (Synaptic systems Cat#135307, 1:1000), mouse anti-synapsin I (Synaptic systems Cat#106011, 1:1000), donkey anti-goat IgG NL-637 (R&amp;D Systems Cat#NL002, 1:1000), donkey anti-mouse IgG NL-493 (R&amp;D Systems Cat#NL009, 1:1000), VAMP2 (Synaptic systems Cat#104211, 1:1000). The following antibodies were used for biochemistry experiments: synapsin-1 (Abcam, Cat#ab254349), c-myc (Sigma, Cat#M4439, 1:500), GFP (Abcam, Cat#ab290, 1:5000). cDNAs of tagged synapsin isoforms, E domain variants, and fluorescent sensors [TagBFP:Synapsin-Ia/Ib/IIa/IIb/IIIa (<xref ref-type="bibr" rid="bib12">Gitler et al., 2004</xref>), TagBFP:Synapsin-Ia<sup>ScrE</sup>, TagBFP:E-domain, EGFP:E-domain, h-α-syn:mCherry, synaptophysinI-2XpHluorin (sypHy) and sypHy:E-domain] were obtained by PCR or digestion of existing plasmids and subcloned into an adeno-associated virus (AAV) backbone that contains the human synapsin promoter, the woodchuck post-transcriptional regulatory element (WPRE) and the bovine growth hormone polyadenlynation signal (bGHpA) (<xref ref-type="bibr" rid="bib17">Kügler et al., 2003</xref>). XFP-tagged synapsin and the E-domain were previously described (<xref ref-type="bibr" rid="bib12">Gitler et al., 2004</xref>). The sequence of the synapsin Ia E-domain was scrambled using the online tool Peptide Nexus (<ext-link ext-link-type="uri" xlink:href="https://peptidenexus.com/article/sequence-scrambler">https://peptidenexus.com/article/sequence-scrambler</ext-link>). A synthetic DNA block (IDT) coding for the scrambled E domain was subcloned using Gibson-cloning (NEB). GST-α-syn 96–140 Scr and GST-α-syn 96–110 Scr plasmids were synthesized by GenScript (Piscataway, NJ, USA). All constructs were verified by sequencing.</p></sec><sec id="s4-2"><title>Hippocampal Cultures, AAV production, and transduction</title><p>Primary hippocampal cultures were obtained using standard procedures as described previously (<xref ref-type="bibr" rid="bib34">Tevet and Gitler, 2016</xref>; <xref ref-type="bibr" rid="bib32">Stavsky et al., 2021</xref>). In brief, P0-P2 pups of either sex were decapitated, and the brains were quickly removed. Dissected hippocampi were kept on ice in Hank’s Balanced Salt Solution (HBSS, Biological Industries) supplemented with 20 mM HEPES at pH 7.4. Hippocampus pieces were incubated for 20 minutes at room temperature (RT) in a digestion solution consisting of HBSS, 1.5 mM CaCl<sub>2</sub>, 0.5 mM EDTA, and 100 units of papain (Worthington, Cat#3127) activated with cysteine (Sigma, Cat#C7352). The brain fragments were then triturated gently two times using fire-polished glass pipettes of decreasing diameter. Cells were seeded at a density of 80,000–100,000 cells per well on glass coverslips (Bar Naor, Cat#BN1001-12-1-CN) coated with poly-D-Lysine (Sigma, Cat#P0899). Cells were plated in Neurobasal-A medium (Thermo Fisher Scientific, Cat#10888022) supplemented with 2% B27 (Thermo Fisher Scientific, Cat#17504044), 2 mM Glutamax I (Thermo Fisher Scientific, Cat#35050038), 5% FBS (Biological Industries, Cat#04-007-1A), and 1 μg/ml gentamicin (Biological Industries, Cat#03-035-1C). After 24 hr, the medium was replaced with serum-free medium containing Neurobasal-A, 2 mM Glutamax I, and 2% B27. Cultures were maintained at 37 °C in a 5% CO<sub>2</sub> humidified incubator until used. For AAV production, HEK293-T cells were co-transfected with the targeting plasmid and two helper plasmids (pD1 and pD2). Hybrid AAV1/2 viral particles were produced as described previously (<xref ref-type="bibr" rid="bib34">Tevet and Gitler, 2016</xref>). Neurons were transduced at 5–6 DIV by adding the viral particles to the growth medium and incubated for at least 7 days before imaging. Viral titers were individually adjusted to produce ⁓90% transduction efficiency. Expressed proteins were verified by western blot and immuno-labeling analysis.</p></sec><sec id="s4-3"><title>pHluorin assays, analysis, and fluorescence microscopy</title><sec id="s4-3-1"><title>Vesicle recycling measurements</title><p>Neurons expressing sypHy were imaged at 12–14 DIV. Experiments were conducted in standard extracellular solution containing (in mM): NaCl 150, KCl 3, Glucose 20, HEPES 10, CaCl<sub>2</sub> 2, MgCl<sub>2</sub> 3, pH adjusted to 7.35. To block recurrent network activity, experiments were conducted in the presence of 10 µM DNQX [6,7-Dinitroquinoxaline-2,3 (1H,4H-dione)] (Sigma, Cat#D0540) and 50 µM APV [DL-2-Amino-5-phosphonopentanoic acid] (Sigma, Cat#A5282). After each experiment, the bath was perfused with saline in which 50 mM NaCl was replaced with NH<sub>4</sub>Cl to visualize the total vesicle population. For imaging, cultured neurons were placed in a stimulation chamber between parallel platinum wires (RC-49MFSH, Warner Instruments). Stimulation (300 bipolar pulses of 10 V/cm, each of a duration of 1 µs, at 20 Hz for 15 s), was delivered using a high-power stimulus-isolation unit (SIU-102B, Warner Instruments) driven by an isolated pulse-stimulator (2100, A-M Systems). Fifty images were obtained (43 at 0.2 Hz and then 7 images at 0.125 Hz) per experiment. At least 30 synaptic regions of interest (ROIs) were analyzed in each case. The baseline sypHy fluorescence (F<sub>0</sub>) in each synapse was the average value measured in 6 pre-stimulation images. The fluorescence increment at time t [ΔF(t)=F(t)-F<sub>0</sub>] was normalized by the baseline value for each synapse. Synaptic ΔF(t)/F<sub>0</sub> values were averaged across manually marked equal-size synaptic ROIs in each experiment (shown as symbols in bar-chart graphs). These were then averaged to obtain mean values for each experimental condition. Non-responding synaptic puncta were excluded. Experiments were performed using at least three independent cultures on different days. Fluorescent-tagged proteins were imaged before each experiment to confirm the presence of h-α-syn-mCherry and tagBFP-synapsins. All pHluorin assays (sypHy) were performed at room temperature. Fluorescence measurements were performed on a Nikon TiE inverted microscope driven by the NIS-elements software package (version 5.21.03, Nikon) (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_014329">SCR_014329</ext-link>) <ext-link ext-link-type="uri" xlink:href="https://www.nikoninstruments.com/Products/Software">https://www.nikoninstruments.com/Products/Software</ext-link>. The microscope was equipped with an Andor Neo 5.5 sCMOS camera (Oxford Instruments), a 40X0.75 NA Plan Fluor objective (Nikon, Cat#MRH00401), a 60X1.4 NA Apochromat oil immersion objective (Nikon, Cat#MRD01602), EGFP (Chroma Technology Corporation, Cat#49002) and Cy3 filter cubes (Chroma Technology Corporation, Cat#49004), BFP (Semrock Cat#LF405-A-000), mCherry (Semrock, Cat#TxRed-4040C) and Cy5 filter cubes (Semrock, Cat#CY5-404A), and a perfect-focus mechanism (Nikon).</p></sec><sec id="s4-3-2"><title>Quantification of endocytosis rates</title><p>Endocytosis rates were assessed based on the decay of sypHy fluorescence after the termination of stimulation. Data were fit with a single-exponential decay-function (32 data points, 160 s) starting 5 s after stimulation cessation. The function is:<disp-formula id="equ1"> , <label>(1)</label><mml:math id="m1"><mml:mi>y</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>A</mml:mi><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mfrac><mml:mrow><mml:mo>-</mml:mo><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>τ</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:msup></mml:math></disp-formula></p><p>where <italic>A</italic> is an amplitude, <italic>y<sub>0</sub></italic> is an offset and <italic>τ</italic> is the time constant, assuming stimulation starts at t=0 for all traces.</p><p>Fit results were discarded if <italic>τ</italic> was longer than 160 s (the duration of the data being fit).</p></sec><sec id="s4-3-3"><title>Measurement of the recycling pool relative size</title><p>The relative size of the recycling pool was calculated based on imaging of cumulative exocytosis. Cumulative exocytosis was achieved by blocking SV reacidification by adding 1 μM bafilomycin A1 (Enzo Life Sciences, Cat#BML-CM110-0100) to the bathing medium itemized above. Neurons were imaged at 0.2 Hz throughout the experiment. Six baseline images were acquired, and stimulation was applied at t=0 for 2 min at 20 Hz (2400 action potentials), until saturation. The fluorescence of the total vesicle population (F<sub>max</sub>) was measured at the end of each experiment by perfusing the chamber with NH<sub>4</sub>Cl-saline. Synaptic sypHy signals were measured from at least 30 ROIs as explained above, subtracting from each its mean baseline value and normalizing it by F<sub>max</sub>. The relative size of the recycling pool was defined as the ratio of the mean of the last three data points (at saturation, before NH<sub>4</sub>Cl exposure) and F<sub>max</sub>.</p></sec><sec id="s4-3-4"><title>Evaluation of width of SV distribution</title><p>Neurons were fixed using 4% paraformaldehyde diluted from a 16% stock (Electron Microscopy Sciences, Cat#15710) in phosphate-buffered saline (Biological Industries, Cat#02-020-1A) for 10 min, washed thoroughly with PBS and permeabilized with PBS supplemented with 0.1% triton X100 (Sigma, Cat#X100-500ML) for 1 min and washed three times. Blocking solution (PBS with 5% skim milk powder; Sigma, Cat#70166–500 G) was applied for 1 hr. The coverslips were incubated for 1 hr with the indicated primary antibodies (see above) in blocking solution at RT, washed X3, and then incubated with secondary antibodies in blocking solution for 1 hr at RT. Finally, the preps were washed X3 and mounted using immumount (Thermo Fisher Scientific, Cat#9990402). Neurons were imaged using a 60X1.4 NA oil-immersion Apochromat objective (Nikon, Cat#MRD01602). Linear profiles were drawn manually along axonal segments and through synaptic puncta in the vGlut1 channel using NIS elements (Nikon). The intensity profiles were imported into Origin (2023) (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_014212">SCR_014212</ext-link>) <ext-link ext-link-type="uri" xlink:href="http://www.originlab.com/index.aspx?go=PRODUCTS/Origin">http://www.originlab.com/index.aspx?go=PRODUCTS/Origin</ext-link> and fit individually with Gaussian functions. The standard deviation parameter (σ) of the fit was extracted, and the FWHM was calculated thus:<disp-formula id="equ2"> <label>(2)</label><mml:math id="m2"><mml:mi>F</mml:mi><mml:mi>W</mml:mi><mml:mi>H</mml:mi><mml:mi>M</mml:mi><mml:mo>=</mml:mo><mml:mn>2</mml:mn><mml:msqrt><mml:mi>l</mml:mi><mml:mi>n</mml:mi><mml:mfenced separators="|"><mml:mrow><mml:mn>4</mml:mn></mml:mrow></mml:mfenced></mml:msqrt><mml:mi>σ</mml:mi><mml:mo>=</mml:mo><mml:mn>2.355</mml:mn><mml:mi>σ</mml:mi></mml:math></disp-formula></p><p>Average FWHM values were calculated per experiment.</p></sec><sec id="s4-3-5"><title>Semi quantitative determination of synaptic fluorescence intensity</title><p>Synaptic puncta were detected as already described (<xref ref-type="bibr" rid="bib22">Orenbuch et al., 2012</xref>), using an in-house thresholding algorithm in which the threshold is iteratively decreased, detected objects are filtered based on their area and roundness (&gt;0.7), saved, and then blanked to not be chosen again. Subsequently, objects that the user judges by eye not to represent synaptic puncta, or those which are out of focus are removed manually. The peak fluorescence at the center-of-mass (2x2 pixels in size) in each punctum was recorded, and synaptic intensity values were averaged per image. All experimental conditions of fluorescence intensity experiments were performed and processed; in each imaging session, the mean intensity value of the control condition was used to normalize all recorded values to reduce inter-session variability. Normalized intensity values were then averaged across sessions. Experiments were performed in at least three independent cultures.</p></sec><sec id="s4-3-6"><title>Measurement of synaptic enrichment</title><p>Synaptic enrichment was measured as described previously (<xref ref-type="bibr" rid="bib3">Atias et al., 2019</xref>). Neurons were transduced at 5 DIV with either sypHy or sypHy-E-domain, h-α-syn-mCherry and soluble tagBFP as a measure of local volume. At 14 DIV, the neurons were fixed and immunostained with anti-vGlut1 antisera to visualize synaptic puncta. Analysis lines (at least 30) were drawn in each image, starting in the axon, through a synapse, and into the surrounding background. The intensity profiles corresponding to the h-α-syn-mCherry and tagBFP channels were fit with a Gaussian function to determine the axonal (<italic>F<sub>axon</sub></italic>) and synaptic (<italic>F<sub>syn</sub></italic>) intensity values of each color thus:<disp-formula id="equ3"> ,<label>(3)</label><mml:math id="m3"><mml:mi>F</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>F</mml:mi></mml:mrow><mml:mrow><mml:mi>a</mml:mi><mml:mi>x</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>F</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>y</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mfrac><mml:mrow><mml:msup><mml:mrow><mml:mfenced separators="|"><mml:mrow><mml:mi>x</mml:mi><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>c</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:mn>2</mml:mn><mml:msup><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mfrac></mml:mrow></mml:msup></mml:math></disp-formula></p><p>where <italic>x<sub>c</sub></italic> is the center of the Gaussian (the synaptic center) and <italic>w</italic> is its width.</p><p>The percentage of synaptic enrichment (<italic>E%</italic>) of h-α-syn-mCherry is defined thus:<disp-formula id="equ4"> <label>(4)</label><mml:math id="m4"><mml:mi>E</mml:mi><mml:mtext>%</mml:mtext><mml:mo>=</mml:mo><mml:mfenced separators="|"><mml:mrow><mml:mfrac><mml:mrow><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>F</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>y</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi></mml:mrow></mml:mfenced></mml:mrow><mml:mo>/</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>F</mml:mi></mml:mrow><mml:mrow><mml:mi>a</mml:mi><mml:mi>x</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:mrow></mml:mrow><mml:mrow><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>F</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>y</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:mfenced></mml:mrow><mml:mo>/</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>F</mml:mi></mml:mrow><mml:mrow><mml:mi>a</mml:mi><mml:mi>x</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:mrow></mml:mrow></mml:mfrac><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfenced><mml:mi>*</mml:mi><mml:mn>100</mml:mn></mml:math></disp-formula></p><p>Protocol available at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.17504/protocols.io.bp2l6xyx5lqe/v1">https://doi.org/10.17504/protocols.io.bp2l6xyx5lqe/v1</ext-link>.</p></sec></sec><sec id="s4-4"><title>Biochemical assays and evaluation</title><sec id="s4-4-1"><title>Preparation of brain and neuro2A lysates</title><p>Whole mouse brains were homogenized with a Dounce tissue grinder in neuronal protein extraction reagent (N-PER) (Thermo Scientific, Cat#87792) containing protease/phosphatase inhibitors (Cell Signaling, Cat#5872). Triton X-100 (Sigma, Cat#X100-500ML) was added to a final concentration of 1%, and the samples were incubated with rotation for 1 hr at 4 °C. Samples were centrifuged at 10,000×<italic>g</italic> for 10 min at 4 °C, and the supernatant was collected. To obtain Neuro2A lysates, cells were washed with 1 X PBS three times and incubated 5 min on ice in the presence of N-PER reagent supplemented with protease inhibitors. Samples were centrifuged at 10,000×<italic>g</italic> for 10 min at 4 °C to remove cellular debris. After obtaining the brain and Neuro2A lysates, we measured protein concentration (DC Protein Assay Kit II, Biorad), and samples were used in subsequent experiments. Protocol available at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.17504/protocols.io.5jyl8pey7g2w/v1">https://doi.org/10.17504/protocols.io.5jyl8pey7g2w/v1</ext-link>.</p></sec><sec id="s4-4-2"><title>Immunoprecipitations and western blots analysis</title><p>Immunoprecipitations were performed using 1–2 mg of total protein. Samples were incubated overnight with the indicated antibody at 4 ° C, followed by the addition of 50 μl of protein G-agarose beads (Thermo Fisher Scientific, Cat#20397). Immunoprecipitated proteins were recovered by centrifugation at 2500×rpm for 2 min, washed three times with a buffer containing PBS and 0.15% Triton X-100 (Sigma, Cat#X100-500ML). The resulting pellets were resuspended in 20 μl of 1 X NuPAGE LDS sample buffer (Thermo Fisher Scientific Cat#NP007) and incubated at 95 °C for 10 min. Samples were separated by NuPAGE 4 to 12% Bis-Tris polyacrylamide gels (Thermo Fisher Scientific, Cat#NP0335BOX), and transferred to a 0.2 µM PVDF membrane (Thermo Fisher Scientific, Cat#LC2002), using the Mini Blot Module system (Thermo Fisher Scientific). PVDF membranes were first fixed with 0.2% PFA 1 x PBS per 30 min at room temperature. Then, membranes were washed three times for 10 min in PBS with 0.1% Tween 20 Detergent (TBST) and blocked for 1 hr in TBST buffer containing 5% dry milk, and then incubated with the indicated primary antibody for 1 hr in blocking solution, washed three times for 10 min each and incubated with HRP-conjugated secondary antibodies (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2819160">AB_2819160</ext-link>, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2755049">AB_2755049</ext-link>). After antibody incubations, membranes were again washed three times with TTBS buffer, and protein bands were visualized using the ChemiDoc Imaging System (Bio-Rad) and quantified with Image Lab software version 6.1 from Bio-Rad (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_014210">SCR_014210</ext-link>) <ext-link ext-link-type="uri" xlink:href="http://www.bio-rad.com/en-us/sku/1709690-image-lab-software">http://www.bio-rad.com/en-us/sku/1709690-image-lab-software</ext-link>. Protocol available at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.17504/protocols.io.36wgq3ep5lk5/v1">https://doi.org/10.17504/protocols.io.36wgq3ep5lk5/v1</ext-link>.</p></sec></sec><sec id="s4-5"><title>GST fusion proteins production</title><p>Full-length recombinant human WT α-syn (Addgene #213498), α-syn 1–95 (Addgene #213499), α-syn 1–110 (Addgene #213500), α-syn 96–140 (Addgene #213501), α-syn 96–140 Scr (Addgene #213502) and α-syn 96–110 Scr (Addgene #213503) were expressed in <italic>Escherichia coli BL21 (DE3)</italic> (New England Biolab, Cat#C2530H) using the bacterial expression vector pGEX-KG myc (Addgene #209891). Following transformation, protein expression was induced with 0.05 mM IPTG (isopropyl-β-d-thiogalactopyranoside), and either incubated at 37 °C for 2 hr or at room temperature for 6 h, with shaking. The cells grown on Terrific Broth (Thermo Scientific, Cat#BP9728-2) were harvested by centrifugation at 4500 × <italic>g</italic> at 4 °C for 20 min, and pellets were stored at –80 °C until use. For protein purification, protein pellets were resuspended in 30 ml Lysis Buffer containing 1 X PBS, 0.5 mg/ml lysozyme, 1 mM PMSF, DNase, and EDTA-free protease cocktail inhibitor (Roche, Cat#11836170001) for 15 min on ice, briefly sonicated (3 sets with 33 strikes and 30 second breaks on ice between sets), and removed the insoluble material by centrifugation at 15,000 × <italic>g</italic> at 4 °C for 30 min. The clarified lysate was incubated with 500 μl of glutathione-Sepharose 4B (Sigma, Cat#17-0756-01), preequilibrated with 1 X PBS containing 0.1% Tween 20 and 5% glycerol (binding buffer), on a tumbler at 4 °C overnight. The GST-bound proteins were washed four times with 30 ml binding buffer and maintained at 4 °C for pull-down assays. Protocol available at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.17504/protocols.io.4r3l22y14l1y/v1">https://doi.org/10.17504/protocols.io.4r3l22y14l1y/v1</ext-link>.</p></sec><sec id="s4-6"><title>Pull-down assays</title><p>To pull down Synapsin Ia from brain lysates, 1–2 mg of the sample was incubated with 25–50 μg of glutathione beads containing GST fusion proteins for 12–16 hr. The mixtures were washed three times with 1 X PBS with 0.15% Triton X-100 (Sigma, Cat#X100-500ML), and then resuspended in 20 μl of 1 X NuPAGE LDS sample buffer for NuPAGE and immunoblotted analysis. Protocol available at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.17504/protocols.io.x54v9pw5pg3e/v1">https://doi.org/10.17504/protocols.io.x54v9pw5pg3e/v1</ext-link>.</p></sec><sec id="s4-7"><title>Statistical analysis</title><p>Results are expressed as mean ± SEM values, and symbols are the results of individual experiments. The normality of the distribution was tested using the Shapiro-Wilk test. Pairs of datasets were compared using the two-sided students’ t-test when deemed to be normally distributed; otherwise, Mann-Whitney’s non-parametric u-test was used. Multiple comparisons of normally distributed datasets were performed using one-way ANOVA or two-way ANOVA, followed by Tukey’s post-hoc analysis. When the distribution of one or more of the compared conditions was deemed not to be distributed normally, the Kruskal-Wallis test was used, with Dunn’s test for posthoc analysis. Outliers were identified using Grubbs’s test. Statistical significance was set at a confidence level of 0.05 for all tests. In all figures: ‘ns’ denotes p ≥ 0.05; * p&lt;0.05; ** p&lt;0.01; and *** p&lt;0.001. Statistical analysis was performed using Origin (2023) (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_014212">SCR_014212</ext-link>) <ext-link ext-link-type="uri" xlink:href="http://www.originlab.com/index.aspx?go=PRODUCTS/Origin">http://www.originlab.com/index.aspx?go=PRODUCTS/Origin</ext-link> or GraphPad Prism software (version 6) (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002798">SCR_002798</ext-link>) <ext-link ext-link-type="uri" xlink:href="http://www.graphpad.com">http://www.graphpad.com</ext-link>.</p></sec><sec id="s4-8"><title>Materials availability</title><p>New reagents are available from the corresponding authors upon request. New plasmids, as indicated in the Key Resources Table will be available through Addgene.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Data curation, Formal analysis, Validation, Investigation, Methodology</p></fn><fn fn-type="con" id="con3"><p>Data curation, Formal analysis, Validation, Investigation, Visualization</p></fn><fn fn-type="con" id="con4"><p>Data curation, Formal analysis, Validation, Investigation, Visualization</p></fn><fn fn-type="con" id="con5"><p>Methodology</p></fn><fn fn-type="con" id="con6"><p>Conceptualization, Data curation, Supervision, Funding acquisition, Visualization, Writing – original draft, Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con7"><p>Conceptualization, Formal analysis, Supervision, Funding acquisition, Validation, Visualization, Methodology, Writing – original draft, Project administration, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation protocols used in this study were approved by the Ben-Gurion University Institutional Committee for Ethical Care and Use of Animals in Research (protocol IL-52-07-2019A) or the UCSD Institutional Animal Care and Use Committee (IACUC protocol S19073). Protocols were executed in accordance with their respective guidelines.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-89687-mdarchecklist1-v1.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>Source data files containing the numerical data used to generate Figure 1 B, C, F, G, Figure 1—figure supplement 1 A, B, D, E, Figure 2 C, G, Figure 3 C, D, F, Figure 3—figure supplement 1 C, Figure 3—figure supplement 2 C, E, Figure 4 C, E, F are appended to the corresponding figure legends. Raw source data (western blots, images, imaging time sequences) were uploaded to Zenodo.</p><p>The following datasets were generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Parra Rivas</surname><given-names>LA</given-names></name></person-group><year iso-8601-date="2023">2023</year><data-title>Synapsin E-domain is essential for α-synuclein function</data-title><source>Zenodo</source><pub-id pub-id-type="doi">10.5281/zenodo.10254061</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset2"><person-group person-group-type="author"><name><surname>Gitler</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2024">2024</year><data-title>Synapsin E-domain is essential for α-synuclein function, Imaging data</data-title><source>Zenodo</source><pub-id pub-id-type="doi">10.5281/zenodo.11067289</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>This work was supported by grant 2019248 from the United States-Israel Binational Science Foundation to Daniel Gitler and Subhojit Roy, grants 1310/19 and 189/22 from the Israel Science Foundation, and the Bergida Endowment on Parkinson’s Disease research to Daniel Gitler, grants to Subhojit Roy from the NINDS (R01NS111978), the Farmer Family Foundation, and a NINDS P30NS047101 grant to the UCSD microscopy core. This research was also funded in whole or in part by Aligning Science Across Parkinson’s [ASAP-020495] through the Michael J Fox Foundation for Parkinson’s Research (MJFF). For the purpose of open access, the author has applied a CC BY public copyright license to all Author Accepted Manuscripts arising from this submission (CC-BY 4.0). Leonardo Parra-Rivas was supported by a postdoctoral fellowship from the American Parkinson’s Disease Association (APDA) and the Parkinson’s Foundation Launch award PF-LAUNCH-1046253.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abeliovich</surname><given-names>A</given-names></name><name><surname>Schmitz</surname><given-names>Y</given-names></name><name><surname>Fariñas</surname><given-names>I</given-names></name><name><surname>Choi-Lundberg</surname><given-names>D</given-names></name><name><surname>Ho</surname><given-names>WH</given-names></name><name><surname>Castillo</surname><given-names>PE</given-names></name><name><surname>Shinsky</surname><given-names>N</given-names></name><name><surname>Verdugo</surname><given-names>JM</given-names></name><name><surname>Armanini</surname><given-names>M</given-names></name><name><surname>Ryan</surname><given-names>A</given-names></name><name><surname>Hynes</surname><given-names>M</given-names></name><name><surname>Phillips</surname><given-names>H</given-names></name><name><surname>Sulzer</surname><given-names>D</given-names></name><name><surname>Rosenthal</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system</article-title><source>Neuron</source><volume>25</volume><fpage>239</fpage><lpage>252</lpage><pub-id pub-id-type="doi">10.1016/s0896-6273(00)80886-7</pub-id><pub-id pub-id-type="pmid">10707987</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anwar</surname><given-names>S</given-names></name><name><surname>Peters</surname><given-names>O</given-names></name><name><surname>Millership</surname><given-names>S</given-names></name><name><surname>Ninkina</surname><given-names>N</given-names></name><name><surname>Doig</surname><given-names>N</given-names></name><name><surname>Connor-Robson</surname><given-names>N</given-names></name><name><surname>Threlfell</surname><given-names>S</given-names></name><name><surname>Kooner</surname><given-names>G</given-names></name><name><surname>Deacon</surname><given-names>RM</given-names></name><name><surname>Bannerman</surname><given-names>DM</given-names></name><name><surname>Bolam</surname><given-names>JP</given-names></name><name><surname>Chandra</surname><given-names>SS</given-names></name><name><surname>Cragg</surname><given-names>SJ</given-names></name><name><surname>Wade-Martins</surname><given-names>R</given-names></name><name><surname>Buchman</surname><given-names>VL</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Functional alterations to the nigrostriatal system in mice lacking all three members of the synuclein family</article-title><source>The Journal of Neuroscience</source><volume>31</volume><fpage>7264</fpage><lpage>7274</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.6194-10.2011</pub-id><pub-id pub-id-type="pmid">21593311</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atias</surname><given-names>M</given-names></name><name><surname>Tevet</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Stavsky</surname><given-names>A</given-names></name><name><surname>Tal</surname><given-names>S</given-names></name><name><surname>Kahn</surname><given-names>J</given-names></name><name><surname>Roy</surname><given-names>S</given-names></name><name><surname>Gitler</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Synapsins regulate α-synuclein functions</article-title><source>PNAS</source><volume>116</volume><fpage>11116</fpage><lpage>11118</lpage><pub-id pub-id-type="doi">10.1073/pnas.1903054116</pub-id><pub-id pub-id-type="pmid">31110014</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boido</surname><given-names>D</given-names></name><name><surname>Farisello</surname><given-names>P</given-names></name><name><surname>Cesca</surname><given-names>F</given-names></name><name><surname>Ferrea</surname><given-names>E</given-names></name><name><surname>Valtorta</surname><given-names>F</given-names></name><name><surname>Benfenati</surname><given-names>F</given-names></name><name><surname>Baldelli</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Cortico-hippocampal hyperexcitability in synapsin I/II/III knockout mice: age-dependency and response to the antiepileptic drug levetiracetam</article-title><source>Neuroscience</source><volume>171</volume><fpage>268</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2010.08.046</pub-id><pub-id pub-id-type="pmid">20804820</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burré</surname><given-names>J</given-names></name><name><surname>Sharma</surname><given-names>M</given-names></name><name><surname>Tsetsenis</surname><given-names>T</given-names></name><name><surname>Buchman</surname><given-names>V</given-names></name><name><surname>Etherton</surname><given-names>MR</given-names></name><name><surname>Südhof</surname><given-names>TC</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro</article-title><source>Science</source><volume>329</volume><fpage>1663</fpage><lpage>1667</lpage><pub-id pub-id-type="doi">10.1126/science.1195227</pub-id><pub-id pub-id-type="pmid">20798282</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burré</surname><given-names>J</given-names></name><name><surname>Sharma</surname><given-names>M</given-names></name><name><surname>Südhof</surname><given-names>TC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Cell biology and pathophysiology of α-synuclein</article-title><source>Cold Spring Harbor Perspectives in Medicine</source><volume>8</volume><elocation-id>a024091</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a024091</pub-id><pub-id pub-id-type="pmid">28108534</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cesca</surname><given-names>F</given-names></name><name><surname>Baldelli</surname><given-names>P</given-names></name><name><surname>Valtorta</surname><given-names>F</given-names></name><name><surname>Benfenati</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The synapsins: key actors of synapse function and plasticity</article-title><source>Progress in Neurobiology</source><volume>91</volume><fpage>313</fpage><lpage>348</lpage><pub-id pub-id-type="doi">10.1016/j.pneurobio.2010.04.006</pub-id><pub-id pub-id-type="pmid">20438797</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denker</surname><given-names>A</given-names></name><name><surname>Rizzoli</surname><given-names>SO</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Synaptic vesicle pools: an update</article-title><source>Frontiers in Synaptic Neuroscience</source><volume>2</volume><elocation-id>135</elocation-id><pub-id pub-id-type="doi">10.3389/fnsyn.2010.00135</pub-id><pub-id pub-id-type="pmid">21423521</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diao</surname><given-names>J</given-names></name><name><surname>Burré</surname><given-names>J</given-names></name><name><surname>Vivona</surname><given-names>S</given-names></name><name><surname>Cipriano</surname><given-names>DJ</given-names></name><name><surname>Sharma</surname><given-names>M</given-names></name><name><surname>Kyoung</surname><given-names>M</given-names></name><name><surname>Südhof</surname><given-names>TC</given-names></name><name><surname>Brunger</surname><given-names>AT</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Native α-synuclein induces clustering of synaptic-vesicle mimics via binding to phospholipids and synaptobrevin-2/VAMP2</article-title><source>eLife</source><volume>2</volume><elocation-id>e00592</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.00592</pub-id><pub-id pub-id-type="pmid">23638301</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fouke</surname><given-names>KE</given-names></name><name><surname>Wegman</surname><given-names>ME</given-names></name><name><surname>Weber</surname><given-names>SA</given-names></name><name><surname>Brady</surname><given-names>EB</given-names></name><name><surname>Román-Vendrell</surname><given-names>C</given-names></name><name><surname>Morgan</surname><given-names>JR</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Synuclein regulates synaptic vesicle clustering and docking at a vertebrate synapse</article-title><source>Frontiers in Cell and Developmental Biology</source><volume>9</volume><elocation-id>774650</elocation-id><pub-id pub-id-type="doi">10.3389/fcell.2021.774650</pub-id><pub-id pub-id-type="pmid">34901020</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fusco</surname><given-names>G</given-names></name><name><surname>Pape</surname><given-names>T</given-names></name><name><surname>Stephens</surname><given-names>AD</given-names></name><name><surname>Mahou</surname><given-names>P</given-names></name><name><surname>Costa</surname><given-names>AR</given-names></name><name><surname>Kaminski</surname><given-names>CF</given-names></name><name><surname>Kaminski Schierle</surname><given-names>GS</given-names></name><name><surname>Vendruscolo</surname><given-names>M</given-names></name><name><surname>Veglia</surname><given-names>G</given-names></name><name><surname>Dobson</surname><given-names>CM</given-names></name><name><surname>De Simone</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Structural basis of synaptic vesicle assembly promoted by α-synuclein</article-title><source>Nature Communications</source><volume>7</volume><elocation-id>12563</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms12563</pub-id><pub-id pub-id-type="pmid">27640673</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gitler</surname><given-names>D</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Kao</surname><given-names>HT</given-names></name><name><surname>Lin</surname><given-names>D</given-names></name><name><surname>Lim</surname><given-names>S</given-names></name><name><surname>Feng</surname><given-names>J</given-names></name><name><surname>Greengard</surname><given-names>P</given-names></name><name><surname>Augustine</surname><given-names>GJ</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Molecular determinants of synapsin targeting to presynaptic terminals</article-title><source>The Journal of Neuroscience</source><volume>24</volume><fpage>3711</fpage><lpage>3720</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5225-03.2004</pub-id><pub-id pub-id-type="pmid">15071120</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greten-Harrison</surname><given-names>B</given-names></name><name><surname>Polydoro</surname><given-names>M</given-names></name><name><surname>Morimoto-Tomita</surname><given-names>M</given-names></name><name><surname>Diao</surname><given-names>L</given-names></name><name><surname>Williams</surname><given-names>AM</given-names></name><name><surname>Nie</surname><given-names>EH</given-names></name><name><surname>Makani</surname><given-names>S</given-names></name><name><surname>Tian</surname><given-names>N</given-names></name><name><surname>Castillo</surname><given-names>PE</given-names></name><name><surname>Buchman</surname><given-names>VL</given-names></name><name><surname>Chandra</surname><given-names>SS</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>αβγ-Synuclein triple knockout mice reveal age-dependent neuronal dysfunction</article-title><source>PNAS</source><volume>107</volume><fpage>19573</fpage><lpage>19578</lpage><pub-id pub-id-type="doi">10.1073/pnas.1005005107</pub-id><pub-id pub-id-type="pmid">20974939</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hilfiker</surname><given-names>S</given-names></name><name><surname>Schweizer</surname><given-names>FE</given-names></name><name><surname>Kao</surname><given-names>HT</given-names></name><name><surname>Czernik</surname><given-names>AJ</given-names></name><name><surname>Greengard</surname><given-names>P</given-names></name><name><surname>Augustine</surname><given-names>GJ</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Two sites of action for synapsin domain E in regulating neurotransmitter release</article-title><source>Nature Neuroscience</source><volume>1</volume><fpage>29</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1038/229</pub-id><pub-id pub-id-type="pmid">10195105</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffmann</surname><given-names>C</given-names></name><name><surname>Sansevrino</surname><given-names>R</given-names></name><name><surname>Morabito</surname><given-names>G</given-names></name><name><surname>Logan</surname><given-names>C</given-names></name><name><surname>Vabulas</surname><given-names>RM</given-names></name><name><surname>Ulusoy</surname><given-names>A</given-names></name><name><surname>Ganzella</surname><given-names>M</given-names></name><name><surname>Milovanovic</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Synapsin condensates recruit alpha-synuclein</article-title><source>Journal of Molecular Biology</source><volume>433</volume><elocation-id>166961</elocation-id><pub-id pub-id-type="doi">10.1016/j.jmb.2021.166961</pub-id><pub-id pub-id-type="pmid">33774037</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffmann</surname><given-names>C</given-names></name><name><surname>Rentsch</surname><given-names>J</given-names></name><name><surname>Tsunoyama</surname><given-names>TA</given-names></name><name><surname>Chhabra</surname><given-names>A</given-names></name><name><surname>Aguilar Perez</surname><given-names>G</given-names></name><name><surname>Chowdhury</surname><given-names>R</given-names></name><name><surname>Trnka</surname><given-names>F</given-names></name><name><surname>Korobeinikov</surname><given-names>AA</given-names></name><name><surname>Shaib</surname><given-names>AH</given-names></name><name><surname>Ganzella</surname><given-names>M</given-names></name><name><surname>Giannone</surname><given-names>G</given-names></name><name><surname>Rizzoli</surname><given-names>SO</given-names></name><name><surname>Kusumi</surname><given-names>A</given-names></name><name><surname>Ewers</surname><given-names>H</given-names></name><name><surname>Milovanovic</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Synapsin condensation controls synaptic vesicle sequestering and dynamics</article-title><source>Nature Communications</source><volume>14</volume><elocation-id>6730</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-023-42372-6</pub-id><pub-id pub-id-type="pmid">37872159</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kügler</surname><given-names>S</given-names></name><name><surname>Kilic</surname><given-names>E</given-names></name><name><surname>Bähr</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Human synapsin 1 gene promoter confers highly neuron-specific long-term transgene expression from an adenoviral vector in the adult rat brain depending on the transduced area</article-title><source>Gene Therapy</source><volume>10</volume><fpage>337</fpage><lpage>347</lpage><pub-id pub-id-type="doi">10.1038/sj.gt.3301905</pub-id><pub-id pub-id-type="pmid">12595892</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lautenschläger</surname><given-names>J</given-names></name><name><surname>Stephens</surname><given-names>AD</given-names></name><name><surname>Fusco</surname><given-names>G</given-names></name><name><surname>Ströhl</surname><given-names>F</given-names></name><name><surname>Curry</surname><given-names>N</given-names></name><name><surname>Zacharopoulou</surname><given-names>M</given-names></name><name><surname>Michel</surname><given-names>CH</given-names></name><name><surname>Laine</surname><given-names>R</given-names></name><name><surname>Nespovitaya</surname><given-names>N</given-names></name><name><surname>Fantham</surname><given-names>M</given-names></name><name><surname>Pinotsi</surname><given-names>D</given-names></name><name><surname>Zago</surname><given-names>W</given-names></name><name><surname>Fraser</surname><given-names>P</given-names></name><name><surname>Tandon</surname><given-names>A</given-names></name><name><surname>St George-Hyslop</surname><given-names>P</given-names></name><name><surname>Rees</surname><given-names>E</given-names></name><name><surname>Phillips</surname><given-names>JJ</given-names></name><name><surname>De Simone</surname><given-names>A</given-names></name><name><surname>Kaminski</surname><given-names>CF</given-names></name><name><surname>Schierle</surname><given-names>GSK</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>C-terminal calcium binding of α-synuclein modulates synaptic vesicle interaction</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>712</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-03111-4</pub-id><pub-id pub-id-type="pmid">29459792</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Logan</surname><given-names>T</given-names></name><name><surname>Bendor</surname><given-names>J</given-names></name><name><surname>Toupin</surname><given-names>C</given-names></name><name><surname>Thorn</surname><given-names>K</given-names></name><name><surname>Edwards</surname><given-names>RH</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>α-Synuclein promotes dilation of the exocytotic fusion pore</article-title><source>Nature Neuroscience</source><volume>20</volume><fpage>681</fpage><lpage>689</lpage><pub-id pub-id-type="doi">10.1038/nn.4529</pub-id><pub-id pub-id-type="pmid">28288128</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milovanovic</surname><given-names>D</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Bian</surname><given-names>X</given-names></name><name><surname>De Camilli</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A liquid phase of synapsin and lipid vesicles</article-title><source>Science</source><volume>361</volume><fpage>604</fpage><lpage>607</lpage><pub-id pub-id-type="doi">10.1126/science.aat5671</pub-id><pub-id pub-id-type="pmid">29976799</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nemani</surname><given-names>VM</given-names></name><name><surname>Lu</surname><given-names>W</given-names></name><name><surname>Berge</surname><given-names>V</given-names></name><name><surname>Nakamura</surname><given-names>K</given-names></name><name><surname>Onoa</surname><given-names>B</given-names></name><name><surname>Lee</surname><given-names>MK</given-names></name><name><surname>Chaudhry</surname><given-names>FA</given-names></name><name><surname>Nicoll</surname><given-names>RA</given-names></name><name><surname>Edwards</surname><given-names>RH</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis</article-title><source>Neuron</source><volume>65</volume><fpage>66</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2009.12.023</pub-id><pub-id pub-id-type="pmid">20152114</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orenbuch</surname><given-names>A</given-names></name><name><surname>Shalev</surname><given-names>L</given-names></name><name><surname>Marra</surname><given-names>V</given-names></name><name><surname>Sinai</surname><given-names>I</given-names></name><name><surname>Lavy</surname><given-names>Y</given-names></name><name><surname>Kahn</surname><given-names>J</given-names></name><name><surname>Burden</surname><given-names>JJ</given-names></name><name><surname>Staras</surname><given-names>K</given-names></name><name><surname>Gitler</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Synapsin selectively controls the mobility of resting pool vesicles at hippocampal terminals</article-title><source>The Journal of Neuroscience</source><volume>32</volume><fpage>3969</fpage><lpage>3980</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5058-11.2012</pub-id><pub-id pub-id-type="pmid">22442064</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parra-Rivas</surname><given-names>LA</given-names></name><name><surname>Madhivanan</surname><given-names>K</given-names></name><name><surname>Aulston</surname><given-names>BD</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Prakashchand</surname><given-names>DD</given-names></name><name><surname>Boyer</surname><given-names>NP</given-names></name><name><surname>Saia-Cereda</surname><given-names>VM</given-names></name><name><surname>Branes-Guerrero</surname><given-names>K</given-names></name><name><surname>Pizzo</surname><given-names>DP</given-names></name><name><surname>Bagchi</surname><given-names>P</given-names></name><name><surname>Sundar</surname><given-names>VS</given-names></name><name><surname>Tang</surname><given-names>Y</given-names></name><name><surname>Das</surname><given-names>U</given-names></name><name><surname>Scott</surname><given-names>DA</given-names></name><name><surname>Rangamani</surname><given-names>P</given-names></name><name><surname>Ogawa</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Serine-129 phosphorylation of α-synuclein is an activity-dependent trigger for physiologic protein-protein interactions and synaptic function</article-title><source>Neuron</source><volume>111</volume><fpage>4006</fpage><lpage>4023</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2023.11.020</pub-id><pub-id pub-id-type="pmid">38128479</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pieribone</surname><given-names>VA</given-names></name><name><surname>Shupliakov</surname><given-names>O</given-names></name><name><surname>Brodin</surname><given-names>L</given-names></name><name><surname>Hilfiker-Rothenfluh</surname><given-names>S</given-names></name><name><surname>Czernik</surname><given-names>AJ</given-names></name><name><surname>Greengard</surname><given-names>P</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Distinct pools of synaptic vesicles in neurotransmitter release</article-title><source>Nature</source><volume>375</volume><fpage>493</fpage><lpage>497</lpage><pub-id pub-id-type="doi">10.1038/375493a0</pub-id><pub-id pub-id-type="pmid">7777058</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Royle</surname><given-names>SJ</given-names></name><name><surname>Granseth</surname><given-names>B</given-names></name><name><surname>Odermatt</surname><given-names>B</given-names></name><name><surname>Derevier</surname><given-names>A</given-names></name><name><surname>Lagnado</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Imaging phluorin-based probes at hippocampal synapses</article-title><source>Methods in Molecular Biology</source><volume>457</volume><fpage>293</fpage><lpage>303</lpage><pub-id pub-id-type="doi">10.1007/978-1-59745-261-8_22</pub-id><pub-id pub-id-type="pmid">19066036</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>DA</given-names></name><name><surname>Tabarean</surname><given-names>I</given-names></name><name><surname>Tang</surname><given-names>Y</given-names></name><name><surname>Cartier</surname><given-names>A</given-names></name><name><surname>Masliah</surname><given-names>E</given-names></name><name><surname>Roy</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A pathologic cascade leading to synaptic dysfunction in alpha-synuclein-induced neurodegeneration</article-title><source>The Journal of Neuroscience</source><volume>30</volume><fpage>8083</fpage><lpage>8095</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1091-10.2010</pub-id><pub-id pub-id-type="pmid">20554859</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>D</given-names></name><name><surname>Roy</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>α-Synuclein inhibits intersynaptic vesicle mobility and maintains recycling-pool homeostasis</article-title><source>The Journal of Neuroscience</source><volume>32</volume><fpage>10129</fpage><lpage>10135</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0535-12.2012</pub-id><pub-id pub-id-type="pmid">22836248</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Senior</surname><given-names>SL</given-names></name><name><surname>Ninkina</surname><given-names>N</given-names></name><name><surname>Deacon</surname><given-names>R</given-names></name><name><surname>Bannerman</surname><given-names>D</given-names></name><name><surname>Buchman</surname><given-names>VL</given-names></name><name><surname>Cragg</surname><given-names>SJ</given-names></name><name><surname>Wade-Martins</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Increased striatal dopamine release and hyperdopaminergic-like behaviour in mice lacking both alpha-synuclein and gamma-synuclein</article-title><source>The European Journal of Neuroscience</source><volume>27</volume><fpage>947</fpage><lpage>957</lpage><pub-id pub-id-type="doi">10.1111/j.1460-9568.2008.06055.x</pub-id><pub-id pub-id-type="pmid">18333965</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shulman</surname><given-names>Y</given-names></name><name><surname>Stavsky</surname><given-names>A</given-names></name><name><surname>Fedorova</surname><given-names>T</given-names></name><name><surname>Mikulincer</surname><given-names>D</given-names></name><name><surname>Atias</surname><given-names>M</given-names></name><name><surname>Radinsky</surname><given-names>I</given-names></name><name><surname>Kahn</surname><given-names>J</given-names></name><name><surname>Slutsky</surname><given-names>I</given-names></name><name><surname>Gitler</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>ATP binding to synaspsin IIa regulates usage and clustering of vesicles in terminals of hippocampal neurons</article-title><source>The Journal of Neuroscience</source><volume>35</volume><fpage>985</fpage><lpage>998</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0944-14.2015</pub-id><pub-id pub-id-type="pmid">25609616</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>SH</given-names></name><name><surname>Augustine</surname><given-names>GJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Synapsin isoforms and synaptic vesicle trafficking</article-title><source>Molecules and Cells</source><volume>38</volume><fpage>936</fpage><lpage>940</lpage><pub-id pub-id-type="doi">10.14348/molcells.2015.0233</pub-id><pub-id pub-id-type="pmid">26627875</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>SH</given-names></name><name><surname>Augustine</surname><given-names>GJ</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Different mechanisms of synapsin-induced vesicle clustering at inhibitory and excitatory synapses</article-title><source>Cell Reports</source><volume>42</volume><elocation-id>113004</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2023.113004</pub-id><pub-id pub-id-type="pmid">37597184</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stavsky</surname><given-names>A</given-names></name><name><surname>Stoler</surname><given-names>O</given-names></name><name><surname>Kostic</surname><given-names>M</given-names></name><name><surname>Katoshevsky</surname><given-names>T</given-names></name><name><surname>Assali</surname><given-names>EA</given-names></name><name><surname>Savic</surname><given-names>I</given-names></name><name><surname>Amitai</surname><given-names>Y</given-names></name><name><surname>Prokisch</surname><given-names>H</given-names></name><name><surname>Leiz</surname><given-names>S</given-names></name><name><surname>Daumer-Haas</surname><given-names>C</given-names></name><name><surname>Fleidervish</surname><given-names>I</given-names></name><name><surname>Perocchi</surname><given-names>F</given-names></name><name><surname>Gitler</surname><given-names>D</given-names></name><name><surname>Sekler</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Aberrant activity of mitochondrial NCLX is linked to impaired synaptic transmission and is associated with mental retardation</article-title><source>Communications Biology</source><volume>4</volume><elocation-id>666</elocation-id><pub-id pub-id-type="doi">10.1038/s42003-021-02114-0</pub-id><pub-id pub-id-type="pmid">34079053</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Bao</surname><given-names>H</given-names></name><name><surname>Premi</surname><given-names>S</given-names></name><name><surname>Das</surname><given-names>U</given-names></name><name><surname>Chapman</surname><given-names>ER</given-names></name><name><surname>Roy</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Functional cooperation of α-synuclein and VAMP2 in synaptic vesicle recycling</article-title><source>PNAS</source><volume>116</volume><fpage>11113</fpage><lpage>11115</lpage><pub-id pub-id-type="doi">10.1073/pnas.1903049116</pub-id><pub-id pub-id-type="pmid">31110017</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tevet</surname><given-names>Y</given-names></name><name><surname>Gitler</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>USing frap or frapa to visualize the movement of fluorescently labeled proteins or cellular organelles in live cultured neurons transformed with adeno-associated viruses</article-title><source>Methods in Molecular Biology</source><volume>1474</volume><fpage>125</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-6352-2_8</pub-id><pub-id pub-id-type="pmid">27515078</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vargas</surname><given-names>KJ</given-names></name><name><surname>Makani</surname><given-names>S</given-names></name><name><surname>Davis</surname><given-names>T</given-names></name><name><surname>Westphal</surname><given-names>CH</given-names></name><name><surname>Castillo</surname><given-names>PE</given-names></name><name><surname>Chandra</surname><given-names>SS</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Synucleins regulate the kinetics of synaptic vesicle endocytosis</article-title><source>The Journal of Neuroscience</source><volume>34</volume><fpage>9364</fpage><lpage>9376</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4787-13.2014</pub-id><pub-id pub-id-type="pmid">25009269</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varkey</surname><given-names>J</given-names></name><name><surname>Isas</surname><given-names>JM</given-names></name><name><surname>Mizuno</surname><given-names>N</given-names></name><name><surname>Jensen</surname><given-names>MB</given-names></name><name><surname>Bhatia</surname><given-names>VK</given-names></name><name><surname>Jao</surname><given-names>CC</given-names></name><name><surname>Petrlova</surname><given-names>J</given-names></name><name><surname>Voss</surname><given-names>JC</given-names></name><name><surname>Stamou</surname><given-names>DG</given-names></name><name><surname>Steven</surname><given-names>AC</given-names></name><name><surname>Langen</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Membrane curvature induction and tubulation are common features of synucleins and apolipoproteins</article-title><source>The Journal of Biological Chemistry</source><volume>285</volume><fpage>32486</fpage><lpage>32493</lpage><pub-id pub-id-type="doi">10.1074/jbc.M110.139576</pub-id><pub-id pub-id-type="pmid">20693280</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Das</surname><given-names>U</given-names></name><name><surname>Scott</surname><given-names>DA</given-names></name><name><surname>Tang</surname><given-names>Y</given-names></name><name><surname>McLean</surname><given-names>PJ</given-names></name><name><surname>Roy</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>α-synuclein multimers cluster synaptic vesicles and attenuate recycling</article-title><source>Current Biology</source><volume>24</volume><fpage>2319</fpage><lpage>2326</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2014.08.027</pub-id><pub-id pub-id-type="pmid">25264250</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yavich</surname><given-names>L</given-names></name><name><surname>Tanila</surname><given-names>H</given-names></name><name><surname>Vepsäläinen</surname><given-names>S</given-names></name><name><surname>Jäkälä</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Role of alpha-synuclein in presynaptic dopamine recruitment</article-title><source>The Journal of Neuroscience</source><volume>24</volume><fpage>11165</fpage><lpage>11170</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2559-04.2004</pub-id><pub-id pub-id-type="pmid">15590933</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yavich</surname><given-names>L</given-names></name><name><surname>Jäkälä</surname><given-names>P</given-names></name><name><surname>Tanila</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Abnormal compartmentalization of norepinephrine in mouse dentate gyrus in alpha-synuclein knockout and A30P transgenic mice</article-title><source>Journal of Neurochemistry</source><volume>99</volume><fpage>724</fpage><lpage>732</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.2006.04098.x</pub-id><pub-id pub-id-type="pmid">16824047</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Augustine</surname><given-names>GJ</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Synapsins and the synaptic vesicle reserve pool: Floats or anchors?</article-title><source>Cells</source><volume>10</volume><elocation-id>658</elocation-id><pub-id pub-id-type="doi">10.3390/cells10030658</pub-id><pub-id pub-id-type="pmid">33809712</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><table-wrap id="app1keyresource" position="anchor"><label>Appendix 1—key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mus musculus</italic>, both sexes)</td><td align="left" valign="bottom">WT mice, C57BL/6JRccHsd</td><td align="left" valign="bottom">Inotiv (Envigo)</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_ENV:HSD-043">IMSR_ENV:HSD-043</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>, both sexes)</td><td align="left" valign="bottom">Synapsin TKO mice</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib12">Gitler et al., 2004</xref>; <xref ref-type="bibr" rid="bib4">Boido et al., 2010</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:MMRRC_041434-JAX">MMRRC_041434-JAX</ext-link></td><td align="left" valign="bottom">Rederived on C57Bl/6 background</td></tr><tr><td align="left" valign="bottom">Cell line (Human)</td><td align="left" valign="bottom">HEK293-T</td><td align="left" valign="bottom">ATCC</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:CVCL_0063">CVCL_0063</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Cell line (Mouse)</td><td align="left" valign="bottom">Neuro2A</td><td align="left" valign="bottom">ATCC</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:CVCL_0470">CVCL_0470</ext-link></td><td align="left" valign="bottom">TKG Cat#TKG 0509</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-vGlut1 (goat polyclonal)</td><td align="left" valign="bottom">Synaptic Systems</td><td align="char" char="." valign="bottom">135 307</td><td align="char" char="." valign="bottom">(IF: 1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-synapsin I (mouse monoclonal)</td><td align="left" valign="bottom">Synaptic Systems</td><td align="char" char="." valign="bottom">106 011</td><td align="char" char="." valign="bottom">(IF: 1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-synapsin-1 (Recombinant)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab254349</td><td align="char" char="." valign="bottom">(WB: 1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-c-myc (mouse monoclonal clone 9E10)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">M4439</td><td align="char" char="." valign="bottom">(WB 1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-GFP (Rabbit polyclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab290</td><td align="char" char="." valign="bottom">(WB 1:5000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-VAMP2 (mouse monoclonal)</td><td align="left" valign="bottom">Synaptic Systems</td><td align="char" char="." valign="bottom">104 211</td><td align="char" char="." valign="bottom">(IF 1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-goat IgG, NL-637 label (Donkey polyclonal)</td><td align="left" valign="bottom">R&amp;D systems</td><td align="left" valign="bottom">NL002</td><td align="char" char="." valign="bottom">(IF 1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-mouse IgG, NL-493 label (Donkey polyclonal)</td><td align="left" valign="bottom">R&amp;D systems</td><td align="left" valign="bottom">NL009</td><td align="char" char="." valign="bottom">(IF 1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-rabbit IgG H&amp;L, HRP (Goat polyclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab205718</td><td align="char" char="." valign="bottom">(WB 1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-mouse IgG H&amp;L, HRP (Goat polyclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab205719</td><td align="char" char="." valign="bottom">(WB 1:1000)</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pD1</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib34">Tevet and Gitler, 2016</xref></td><td align="left" valign="bottom">AAV1</td><td align="left" valign="bottom">Cap1, Rep2, E2A, E4, VA</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pD2</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib34">Tevet and Gitler, 2016</xref></td><td align="left" valign="bottom">AAV2</td><td align="left" valign="bottom">Cap2, Rep2, E2A, E4, VA</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pAAV2-hSyn-sypHy</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib22">Orenbuch et al., 2012</xref></td><td align="left" valign="bottom">DG87</td><td align="left" valign="bottom">hSyn (promoter) Synaptophysin I –2XpHluorin</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pAAV2-hSyn-sypHy:E-domain</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">DG189</td><td align="left" valign="bottom">hSyn (promoter) Synaptophysin I –2XpHluorin – Synapsin Ia E domain</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pAAV2-hSyn-tagBFP</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">DG138</td><td align="left" valign="bottom">hSyn (promoter) tagBFP</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pAAV2-hSyn-tagBFP:E-domain</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">DG201</td><td align="left" valign="bottom">hSyn (promoter) tagBFP-Synapsin Ia E domain</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pAAV2-hSyn-tagBFP:ScrE-domain</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">DG200</td><td align="left" valign="bottom">hSyn (promoter) tagBFP- Scrambled Synapsin Ia E domain</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pAAV2-hSyn-EGFP:E-domain</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">DG187</td><td align="left" valign="bottom">hSyn (promoter) EGFP-Synapsin Ia E domain</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pAAV2-hSyn-h-α-syn-mCherry</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib3">Atias et al., 2019</xref></td><td align="left" valign="bottom">DG79</td><td align="left" valign="bottom">hSyn (promoter) human-alpha-synuclein-mCherry</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pAAV2-hSyn- mCherry</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib3">Atias et al., 2019</xref></td><td align="left" valign="bottom">DG97</td><td align="left" valign="bottom">hSyn (promoter) mCherry</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pEYFPC1-Synapsin Ia</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib12">Gitler et al., 2004</xref><break/></td><td align="left" valign="bottom">Syn03</td><td align="left" valign="bottom">CMV (enhancer +promoter) EYFP-Synapsin Ia</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pEGFPC1-Synapsin Ib</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib12">Gitler et al., 2004</xref></td><td align="left" valign="bottom">Syn65</td><td align="left" valign="bottom">CMV (enhancer +promoter) EGFP-Synapsin Ib</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pEGFPC1-Synapsin IIa</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib12">Gitler et al., 2004</xref></td><td align="left" valign="bottom">Syn50</td><td align="left" valign="bottom">CMV (enhancer +promoter) EGFP-Synapsin IIa</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pEGFPC2-Synapsin IIb</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib12">Gitler et al., 2004</xref></td><td align="left" valign="bottom">Syn73</td><td align="left" valign="bottom">CMV (enhancer +promoter) EGFP-Synapsin IIb</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pEGFPC1-Synapsin IIIa</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib12">Gitler et al., 2004</xref></td><td align="left" valign="bottom">Syn59</td><td align="left" valign="bottom">CMV (enhancer +promoter) EGFP-Synapsin IIIa</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pEYFPC1-Synapsin Ia ScrE</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">Syn88</td><td align="left" valign="bottom">CMV (enhancer +promoter) EYFP-Synapsin Ia Scrambled E domain</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pEYFPC1</td><td align="left" valign="bottom">Clontech</td><td align="left" valign="bottom"/><td align="left" valign="bottom">CMV (enhancer +promoter) EYFP</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pEGFPC1</td><td align="left" valign="bottom">Clontech</td><td align="left" valign="bottom"/><td align="left" valign="bottom">CMV (enhancer +promoter) EGFP</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">h-α-syn-myc</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">pLP351</td><td align="left" valign="bottom">EF-1 alpha promoter (pCCL backbone)</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">GST</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib23">Parra-Rivas et al., 2023</xref></td><td align="left" valign="bottom">Addgene # 209891</td><td align="left" valign="bottom">pGEX-KG myc</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">GST-h-α-syn FL</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">Addgene # 213498</td><td align="left" valign="bottom">pGEX-KG myc backbone</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">GST-h-α-syn 1–95</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">Addgene # 213499</td><td align="left" valign="bottom">pGEX-KG myc backbone</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">GST-h-α-syn 1–110</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">Addgene # 213500</td><td align="left" valign="bottom">pGEX-KG myc backbone</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">GST-h-α-syn 96–140</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">Addgene # 213501</td><td align="left" valign="bottom">pGEX-KG myc backbone</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">GST-h-α-syn FL Scrambled 96–110</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">Addgene # 213503</td><td align="left" valign="bottom">pGEX-KG myc backbone</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">GST-h-α-syn FL Scrambled 96–140</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">Addgene # 213502</td><td align="left" valign="bottom">pGEX-KG myc backbone</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pAAV2-hSyn-tagBFP-Synapsin Ia</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">DG199</td><td align="left" valign="bottom">hSyn (promoter) tagBFP-Synapsin Ia</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pAAV2-hSyn-tagBFP-Synapsin Ib</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">DG150</td><td align="left" valign="bottom">hSyn (promoter) tagBFP-Synapsin Ib</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pAAV2-CMV/CBAP-tagBFP-Synapsin IIa</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib22">Orenbuch et al., 2012</xref></td><td align="left" valign="bottom">DG18</td><td align="left" valign="bottom">CMV-CBAP (promoter) tagBFP-Synapsin IIa</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pAAV2-hSyn-tagBFP-Synapsin IIb</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">DG160</td><td align="left" valign="bottom">hSyn (promoter) tagBFP-Synapsin IIb</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pAAV2-hSyn-tagBFP-Synapsin IIIa</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">DG153</td><td align="left" valign="bottom">hSyn (promoter) tagBFP-Synapsin IIIa</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Bafilomycin A1</td><td align="left" valign="bottom">Enzo Life Sciences</td><td align="left" valign="bottom">BML-CM110-0100</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">6,7-Dinitroquinoxaline-2,3 (1H,4H-dione), DNQX</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">D0540</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">DL-2-Amino-5-phosphonopentanoic acid, APV</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">A5282</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Origin Pro 2023</td><td align="left" valign="bottom">Originlab</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_014212">SCR_014212</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">GraphPad Prism 6</td><td align="left" valign="bottom">Graphpad</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002798">SCR_002798</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">NIS-elements AR 5.21.03</td><td align="left" valign="bottom">Nikon</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_014329">SCR_014329</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">N-PER</td><td align="left" valign="bottom">Thermo Scientific</td><td align="char" char="." valign="bottom">87792</td><td align="left" valign="bottom">Methods: Biochemical assays and evaluation</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">protease/ phosphatase inhibitors</td><td align="left" valign="bottom">Cell Signaling</td><td align="char" char="." valign="bottom">5872</td><td align="left" valign="bottom">Methods: Biochemical assays and evaluation</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Neurobasal-A medium</td><td align="left" valign="bottom">Thermo-Fisher Scientific</td><td align="char" char="." valign="bottom">10888022</td><td align="left" valign="bottom">Methods: Hippocampal Cultures, AAV production, and transduction</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">B27 supplement</td><td align="left" valign="bottom">Thermo-Fisher Scientific</td><td align="char" char="." valign="bottom">17504044</td><td align="left" valign="bottom">Methods: Hippocampal Cultures, AAV production, and transduction</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Glutamax I</td><td align="left" valign="bottom">Thermo-Fisher Scientific</td><td align="char" char="." valign="bottom">35050038</td><td align="left" valign="bottom">Methods: Hippocampal Cultures, AAV production, and transduction</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Fetal Bovine Serum, European Grade</td><td align="left" valign="bottom">Biological Industries</td><td align="char" char="hyphen" valign="bottom">04-007-1A</td><td align="left" valign="bottom">Methods: Hippocampal Cultures, AAV production, and transduction</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Gentamicin</td><td align="left" valign="bottom">Biological Industries</td><td align="char" char="hyphen" valign="bottom">03-035-1C</td><td align="left" valign="bottom">Methods: Hippocampal Cultures, AAV production, and transduction</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">immumount</td><td align="left" valign="bottom">Thermo Scientific</td><td align="char" char="." valign="bottom">9990402</td><td align="left" valign="bottom">Methods: pHluorin assays, analysis, and fluorescence microscopy</td></tr></tbody></table></table-wrap></app></app-group></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.89687.3.sa0</article-id><title-group><article-title>eLife assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Slutsky</surname><given-names>Inna</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>Tel Aviv University</institution><country>Israel</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Compelling</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Important</kwd></kwd-group></front-stub><body><p>Alpha-synuclein is a synaptic vesicle associated protein that is linked to a number of neurodegenerative disorders. In this manuscript, the authors provide <bold>compelling</bold> evidence of alpha-synuclein's interaction with E-domain synapsins as the main culprit mediating the suppression of neurotransmitter release and synaptic vesicle recycling by alpha-synuclein. This <bold>important</bold> work provides molecular mechanisms underlying alpha-synuclein functions.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.89687.3.sa1</article-id><title-group><article-title>Reviewer #1 (Public Review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>This is a short but important study. Basically, the authors show that α-synuclein overexpression's negative impact on synaptic vesicle recycling is mediated by its interaction with E-domain containing synapsins. This finding is highly relevant for synuclein function as well as for the pathophysiology of synucleinopathies. The data is clear, functional analysis is highly adequate.</p></body></sub-article><sub-article article-type="author-comment" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.89687.3.sa2</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Stavsky</surname><given-names>Alexandra</given-names></name><role specific-use="author">Author</role><aff><institution>Ben-Gurion University of the Negev</institution><addr-line><named-content content-type="city">Beer Sheva</named-content></addr-line><country>Israel</country></aff></contrib><contrib contrib-type="author"><name><surname>Parra-Rivas</surname><given-names>Leonardo A</given-names></name><role specific-use="author">Author</role><aff><institution>UCSD</institution><addr-line><named-content content-type="city">SAN DIEGO</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Tal</surname><given-names>Shani</given-names></name><role specific-use="author">Author</role><aff><institution>Ben-Gurion University of the Negev</institution><addr-line><named-content content-type="city">Beer Sheva</named-content></addr-line><country>Israel</country></aff></contrib><contrib contrib-type="author"><name><surname>Riba</surname><given-names>Jen</given-names></name><role specific-use="author">Author</role><aff><institution>Ben-Gurion University of the Negev</institution><addr-line><named-content content-type="city">Beer Sheva</named-content></addr-line><country>Israel</country></aff></contrib><contrib contrib-type="author"><name><surname>Madhivanan</surname><given-names>Kayalvizhi</given-names></name><role specific-use="author">Author</role><aff><institution>UCSD</institution><addr-line><named-content content-type="city">La Jolla</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Roy</surname><given-names>Subhojit</given-names></name><role specific-use="author">Author</role><aff><institution>UCSD</institution><addr-line><named-content content-type="city">La Jolla</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Gitler</surname><given-names>Daniel</given-names></name><role specific-use="author">Author</role><aff><institution>Ben-Gurion University of the Negev</institution><addr-line><named-content content-type="city">Beer Sheva</named-content></addr-line><country>Israel</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the original reviews.</p><disp-quote content-type="editor-comment"><p>Reviewer #1</p><p>This is a short but important study. Basically, the authors show that α-synuclein overexpression's negative impact on synaptic vesicle recycling is mediated by its interaction with E-domain containing synapsins. This finding is highly relevant for synuclein function as well as for the pathophysiology of synucleinopathies. While the data is clear, functional analysis is somewhat incomplete.</p><p>(1) The authors should present a clearer dissociation of endocytosis and exocytosis under the various conditions they study. They should quantify the rate of rise and decay of pHluorin signals.</p></disp-quote><p>1. In addition, I strongly recommend a few additional experiments with and without a vATPase inhibitor such as bafilomycin to estimate the relative effects on exo- vs. endocytosis. As the authors are aware bafilomycin will mask the re-acidification /endocytosis component, thus revealing pure exocytosis and thus enabling quantification of endocytosis with minimal contamination from exocytosis.</p><p>In the revised version, we analyzed and quantified exocytosis and endocytosis separately, with bafilomycin experiments, as the reviewer suggested (new data, Fig. 1- Fig. Supp. 1A-B). Overexpression of human alpha-synuclein only attenuated exocytosis in neurons that also expressed synapsins (WT neurons and synapsin TKO neurons transduced with synapsin Ia). In parallel, we also examined endocytosis by calculating the time-constant of the decay in the fluorescence of sypHy during the endocytotic phase (Fig. 1- Fig. Supp. 1C-E). Previous studies have shown that after brief stimulus-trains – like those used in our study (20Hz/300AP) – most endocytosis occurs after the cessation of stimulation 1. Expression of human alpha-synuclein did not alter the endocytosis time-constant in any of our experiments. To summarize, the interaction of alpha-synuclein with the synapsin E domain was required for alpha-synuclein induced attenuation of exocytosis, but not endocytosis.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2</bold></p><p>...The paper will be improved significantly if additional experiments are added to expand and provide a more mechanistic understanding of the effect of α-syn and the intricate interplay between synapsin, α-syn, and the SV. For an enthusiastic reader, the manuscript as it looks now with only 3 figures, ends prematurely. Some of the experiments above or others could complement, expand and strengthen the current manuscript, moving it from a short communication describing the phenomenon to a coherent textbook topic. Nevertheless, this work provides new and exciting evidence for the regulation of neurotransmitter release and its regulation by synapsin and α-syn.</p><p>(1) Did the authors try to attach E-domain for example to synapsin Ib and restore α-syn inhibition with synapsin Ib-E?</p></disp-quote><p>This is an interesting idea, but in previous studies, we found that synapsin Ib does not associate with synaptic vesicles2, so it will not be present at the right location to be able to restore alpha-synuclein induced synaptic attenuation. We have also seen that this mis-localization alters synaptic properties (unpublished).</p><disp-quote content-type="editor-comment"><p>(2) Was the expression level of Synapsin-IaScrE examined and compared to WT Synapsin-Ia in Fig 3?</p></disp-quote><p>Yes, this data is now shown in Fig. 3-Fig. Supp. 1.</p><disp-quote content-type="editor-comment"><p>(3) Were SVs dispersed in α-syn overexpression as predicted?</p></disp-quote><p>We interpret the reviewer’s question and reasoning as follows. If alpha-synuclein binds to the E-domain of synapsin, a prediction in the alpha-synuclein over-expression scenario is that the overabundance of alpha-synuclein molecules would bind to and sequester the E-domain synapsins away from synaptic vesicles. In the absence of E-domain synapsins, the synaptic-vesicle clustering effects of synapsins would be lost, and there would be dispersion of synaptic vesicles. We tested this prediction, which is now shown in an additional figure (new data, Fig. 4). Indeed, the AAV-mediated over-expression of alpha-synuclein leads to a dispersion of synaptic vesicles, and this dispersion is dependent on synapsins Ia and Ib, but not IIa and IIb (please see Fig. 4D-E in the revised manuscript). Appropriate text is also added, starting with “Previous studies have shown that loss of all synapsins...” presents this data and interprets it.</p><disp-quote content-type="editor-comment"><p>(4) How does this study coincide with the effects of α-syn on fusion pore and endocytosis? This should be at least discussed. It is also possible that the effects of α-syn on endocytosis might affect the results as if endocytosis is affected, SVs number and distribution will be also affected.</p></disp-quote><p>It is difficult to reconcile our data with the idea that alpha-synuclein facilitates fusion-pore opening, as proposed by the Edwards lab 3. In fact, its difficult to reconcile this concept with their own previous data, showing that alpha-synuclein over-expression attenuates SV-recycling 4. As mentioned above, modulation of endocytosis does not seem to be a major factor in our experiments, though this does not rule out a physiologic role for alpha-synuclein in endocytosis, since all our experiments are based on over-expression paradigms. Future experiments looking at phenotypes after acute alpha-synuclein knockdown may provide more clarity. In any case, there are many purported roles of alpha-synuclein, and this is now mentioned in the last paragraph starting with Additionally, α-syn has been implicated…”</p><disp-quote content-type="editor-comment"><p>(5) What happened after stimulation when synapsin is detached from SV, does α-syn continues to be linked to it?</p></disp-quote><p>The fate of alpha-synuclein after stimulation is unclear in our experiments. Previous experiments suggest that while both synapsin and alpha-synuclein detach from the SV cluster during stimulation, synapsin returns to synapses while alpha-synuclein does not 5. However, our more recent experiments (unpublished) suggest that the activity-induced dispersion of alpha-synuclein might be phosphorylation-dependent, and that over-expression of alpha-synuclein may not be the best setting to evaluate protein dispersion. We hope to answer this question more rigorously using alpha-synuclein knock-in constructs.</p><disp-quote content-type="editor-comment"><p>(6) The experiment with E-domain fused to syPhy assumes that α-syn will still be bound to the SV. So how does α-syn inhibit ST?</p></disp-quote><p>The goal of this experiment was to force the synapsin E-domain to be in a location where it would normally be present – i.e. surface of the synaptic vesicle – by tagging it to sypHy (sypHy-E), and ask if this forced-retention would be sufficient to reinstate the alpha-synuclein mediated attenuation of SV-recycling (as shown in Fig. 3F, it does). Please note that the sypHy-E in these experiments does target to the synapses (new data, Fig. 3-Fig. Supp. 2D). In this context, we are not sure what the reviewer means by “So how does a-syn inhibit synaptic transmission?” We don’t think that alpha-synuclein needs to unbind from the SVs in order to inhibit synaptic transmission. Overall, we think that alpha-synuclein needs to cooperate with synapsins to perform its function, but as mentioned above and in the manuscript, the precise role of alpha-synuclein in this process is still unclear.</p><disp-quote content-type="editor-comment"><p>(7) An interesting experiment will be the expression of the isolated E-domain and examining blockage of α-syn inhibition and disruption of synapsin- α-syn interaction. Have the authors examined it as was done in other models?</p></disp-quote><p>We did do the experiment where we only over-expressed the isolated synapsin E-domain in neurons. We were thinking that perhaps the E-domain would have a dominant-negative effect on SV-clustering, as it did in the lamprey and other model-systems, where the E-peptide was directly injected into the axon. However, we found that in cultured hippocampal neurons, the over-expressed E-domain behaves like a soluble protein and is not enriched in synapses (see new data, Fig. 3-Fig. Supp. 2B). Also, the over-expressed E-domain cannot reinstate the synaptic attenuation induced by alpha-synuclein (new data, Fig. 3-Fig. Supp. 2C), likely because the E-domain does not target to synapses. Actually, this is why we did the syPhy-E domain experiment in the first place, to ensure that the E-domain was in the right location to have an effect.</p><disp-quote content-type="editor-comment"><p>(8) A schematic model/scheme providing a mechanistic view of the interplay between the proteins is essential and can improve the paper.</p></disp-quote><p>The only model we can confidently make right now would be stick-figures showing the site where alpha-synuclein C-terminus binds to synapsin, which is obviously not very insightful. As noted above (and in the revised version), several different functions have been attributed to alpha-synuclein, and the precise role of alpha-synuclein/synapsin interactions in regulating the SV-cycle is unclear. We hope to create a better model after getting some more data from us and our colleagues working on this challenging problem.</p><p>References</p><p>(1) Kononenko NL &amp; Haucke V. (2015) Molecular mechanisms of presynaptic membrane retrieval and synaptic vesicle reformation. Neuron 85, 484-496.</p><p>(2) Gitler D, Xu Y, Kao H-T, Lin D, Lim S, Feng J, Greengard P &amp; Augustine GJ. (2004) Molecular Determinants of Synapsin Targeting to Presynaptic Terminals. J. Neurosci. 24, 3711-3720.</p><p>(3) Logan T, Bendor J, Toupin C, Thorn K &amp; Edwards RH. (2017) α-Synuclein promotes dilation of the exocytotic fusion pore. Nat Neurosci 20, 681-689.</p><p>(4) Nemani VM, Lu W, Berge V, Nakamura K, Onoa B, Lee MK, Chaudhry FA, Nicoll RA &amp; Edwards RH. (2010) Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis. Neuron 65, 66-79.</p><p>(5) Fortin DL, Nemani VM, Voglmaier SM, Anthony MD, Ryan TA &amp; Edwards RH. (2005) Neural activity controls the synaptic accumulation of alpha-synuclein. J Neurosci 25, 10913-10921.</p></body></sub-article></article>